CA2190528A1 - Primate embryonic stem cells - Google Patents
Primate embryonic stem cellsInfo
- Publication number
- CA2190528A1 CA2190528A1 CA002190528A CA2190528A CA2190528A1 CA 2190528 A1 CA2190528 A1 CA 2190528A1 CA 002190528 A CA002190528 A CA 002190528A CA 2190528 A CA2190528 A CA 2190528A CA 2190528 A1 CA2190528 A1 CA 2190528A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- preparation
- differentiate
- embryonic stem
- ssea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
Abstract
A purified preparation of primate embryonic stem cells is disclosed. This preparation is characterized by the following cell surface markers: SSEA-1 (-); SSEA-3 (+); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+); and alkaline phosphatase (+). In a paricularly advantageous embodiment, the cells of the preparation have normal karyotypes and continue to proliferate in an undifferentiated state after continuous culture for eleven months. The embryonic stem cell lines also retain the ability, throughout the culture, to form trophoblast and to differentiate into all tissues derived from all three embryonic germ layers (endoderm, mesoderm and ectoderm). A method for isolating a primate embryonic stem cell line is also disclosed.
Claims (11)
1. A purified preparation of primate embryonic stem cells which (i) is capable of proliferation in vitro culture for over one year, (ii) maintains a normal karyotype through prolonged culture, (iii) maintains the potential to differentiate to derivatives of endoderm, mesoderm, and ectoderm tissues throughout the culture, and (iv) will not differentiate when cultured on a fibroblast feeder layer.
2. The preparation of claim 1 wherein the stem cells will spontaneously differentiate to trophoblast and produce chorionic gonadotropin when cultured to high density.
3. A purified preparation of primate embryonic stem cells wherein the cells are negative for the SSEA-1 marker, positive for the SSEA-3 marker, positive for the SSEA-4 marker, express alkaline phosphatase activity, are pluripotent, and have normal karyotypes.
4. The preparation of claim 3 wherein the cells are positive for the TRA-1-60, and TRA-1-81 markers.
5. The preparation of claim 3 wherein the cells continue to proliferate in an undifferentiated state after continuous culture for at least one year.
6. The preparation of claim 3 wherein the cells will differentiate to trophoblast when cultured beyond confluence and will produce chorionic gonadotropin.
7. The preparation of claim 3 wherein the cells remain euploid for more than one year of continuous culture.
8. The preparation of claim 3 wherein the cells differentiate into cells derived from mesoderm, endoderm and ectoderm germ layers when the cells are injected into a SCID mouse.
9. A method of isolating a primate embryonic stem cell line, comprising the steps of:
(a) isolating a primate blastocyst;
(b) isolating cells from the inner cell mass of the blastocyte of (a);
(c) plating the inner cell mass cells on embryonic fibroblasts, wherein inner cell mass-derived cell masses are formed;
(d) dissociating the mass into dissociated cells;
(e) replating the dissociated cells on embryonic feeder cells;
(f) selecting colonies with compact morphologies and cells with high nucleus to cytoplasm ratios and prominent nucleoli; and (g) culturing the cells of the selected colonies.
(a) isolating a primate blastocyst;
(b) isolating cells from the inner cell mass of the blastocyte of (a);
(c) plating the inner cell mass cells on embryonic fibroblasts, wherein inner cell mass-derived cell masses are formed;
(d) dissociating the mass into dissociated cells;
(e) replating the dissociated cells on embryonic feeder cells;
(f) selecting colonies with compact morphologies and cells with high nucleus to cytoplasm ratios and prominent nucleoli; and (g) culturing the cells of the selected colonies.
10. A method as claimed in claim 9 further comprising maintaining the isolated cells on a fibroblast feeder layer to prevent differentiation.
11. A cell line developed by the method of step 9.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37632795A | 1995-01-20 | 1995-01-20 | |
US08/376,327 | 1995-01-20 | ||
PCT/US1996/000596 WO1996022362A1 (en) | 1995-01-20 | 1996-01-19 | Primate embryonic stem cells |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2190528A1 true CA2190528A1 (en) | 1996-07-25 |
CA2190528C CA2190528C (en) | 2010-04-27 |
Family
ID=23484566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2190528A Expired - Lifetime CA2190528C (en) | 1995-01-20 | 1996-01-19 | Primate embryonic stem cells |
Country Status (5)
Country | Link |
---|---|
US (11) | US5843780A (en) |
EP (2) | EP1640448A3 (en) |
AU (1) | AU4758496A (en) |
CA (1) | CA2190528C (en) |
WO (1) | WO1996022362A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7413902B2 (en) | 1997-10-23 | 2008-08-19 | Geron Corporation | Feeder-free culture method for embryonic stem cells or primate primordial stem cells |
US8637311B2 (en) | 1998-10-23 | 2014-01-28 | Asterias Biotherapeutics, Inc. | Human embryonic stem cells genetically modified to contain a nucleic acid and cultured with fibroblast growth factor |
Families Citing this family (803)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030032178A1 (en) * | 1988-08-04 | 2003-02-13 | Williams Robert Lindsay | In vitro propagation of embryonic stem cells |
US7153684B1 (en) * | 1992-10-08 | 2006-12-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
CA2157931A1 (en) * | 1993-03-12 | 1994-09-15 | Clague P. Hodgson | Improved vectors for gene therapy |
US20040071637A1 (en) * | 1993-04-27 | 2004-04-15 | Elia James P. | Method for repairing a damaged portion of a human organ |
US5874301A (en) * | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US7112440B2 (en) | 1995-02-02 | 2006-09-26 | Ghazi Jaswinder Dhoot | Method of increasing the relative number of CD45 low cells in a cell population |
US9068164B1 (en) | 1995-02-02 | 2015-06-30 | Tristem Trading (Cyprus) Limited | Method of preparing an undifferentiated cell |
US7410773B2 (en) * | 1995-02-02 | 2008-08-12 | Ghazi Jaswinder Dhoot | Method of preparing an undifferentiated cell |
GB9502022D0 (en) * | 1995-02-02 | 1995-03-22 | Abuljadayel Ilham M S | A method for preparing lymphohaematopoietic progenitor cells |
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
US20030190753A1 (en) * | 1995-11-09 | 2003-10-09 | Nature Technology Corporation | Vectors for gene transfer |
US7544511B2 (en) * | 1996-09-25 | 2009-06-09 | Neuralstem Biopharmaceuticals Ltd. | Stable neural stem cell line methods |
WO1997047734A1 (en) * | 1996-06-14 | 1997-12-18 | The Regents Of The University Of California | In vitro derivation and culture of primate pluripotent stem cells and therapeutic uses thereof |
US20020194637A1 (en) * | 2001-06-06 | 2002-12-19 | University Of Massachussetts | Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
US7696404B2 (en) * | 1996-08-19 | 2010-04-13 | Advanced Cell Technology, Inc. | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
US6331406B1 (en) | 1997-03-31 | 2001-12-18 | The John Hopkins University School Of Medicine | Human enbryonic germ cell and methods of use |
US6090622A (en) * | 1997-03-31 | 2000-07-18 | The Johns Hopkins School Of Medicine | Human embryonic pluripotent germ cells |
DE69840439D1 (en) | 1997-04-24 | 2009-02-26 | Univ Washington | TARGETED GENERIC CHANGE WITH PARVOVIRAL VECTORS |
WO1999001763A2 (en) * | 1997-07-02 | 1999-01-14 | Board Of Regents, The University Of Texas System | p53 AS A REGULATOR OF CELL DIFFERENTIATION |
WO1999027076A1 (en) * | 1997-11-25 | 1999-06-03 | Arc Genomic Research | Pluripotent embryonic stem cells and methods of obtaining them |
US20050096274A1 (en) * | 1998-04-07 | 2005-05-05 | Lough John W. | Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
ES2246085T3 (en) * | 1998-05-07 | 2006-02-01 | University Of South Florida | OSEA MEDULA CELLS AS A SOURCE OF NEURONS USEFUL TO REPAIR THE SPINAL MEDULA AND THE BRAIN. |
US20080206206A1 (en) | 1998-05-07 | 2008-08-28 | University Of South Florida | Bone marrow-derived neuronal cells |
US6767737B1 (en) * | 1998-08-31 | 2004-07-27 | New York University | Stem cells bearing an FGF receptor on the cell surface |
AU3881499A (en) * | 1998-09-01 | 2000-03-21 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells with compatible histocompatibility genes |
WO2000017325A1 (en) * | 1998-09-23 | 2000-03-30 | Mount Sinai Hospital | Trophoblast cell preparations |
US6667176B1 (en) | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
US7413904B2 (en) * | 1998-10-23 | 2008-08-19 | Geron Corporation | Human embryonic stem cells having genetic modifications |
US20020168766A1 (en) * | 2000-01-11 | 2002-11-14 | Gold Joseph D. | Genetically altered human pluripotent stem cells |
IL142748A0 (en) * | 1998-11-09 | 2002-03-10 | Univ Monash | Embryonic stem cells |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
US6455311B1 (en) * | 1999-04-30 | 2002-09-24 | The General Hospital Corporation | Fabrication of vascularized tissue |
US7759113B2 (en) * | 1999-04-30 | 2010-07-20 | The General Hospital Corporation | Fabrication of tissue lamina using microfabricated two-dimensional molds |
US7371400B2 (en) | 2001-01-02 | 2008-05-13 | The General Hospital Corporation | Multilayer device for tissue engineering |
IL129966A (en) * | 1999-05-14 | 2009-12-24 | Technion Res & Dev Foundation | ISOLATED HUMAN EMBRYOID BODIES (hEB) DERIVED FROM HUMAN EMBRYONIC STEM CELLS |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US8252280B1 (en) | 1999-08-05 | 2012-08-28 | Regents Of The University Of Minnesota | MAPC generation of muscle |
US10638734B2 (en) | 2004-01-05 | 2020-05-05 | Abt Holding Company | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
CN1379814A (en) * | 1999-09-14 | 2002-11-13 | 马萨诸塞大学 | Embryonic or stem-like cell lines produced by cross species nuclear transpcantation and methods for enhancing mebryonic development by genetic alteration of donor cells or by tissue culture conditions |
EP1218489B1 (en) * | 1999-09-24 | 2009-03-18 | Cybios LLC | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
AUPQ307399A0 (en) * | 1999-09-24 | 1999-10-21 | Luminis Pty Limited | Cell cycle control |
CA2388497A1 (en) * | 1999-10-15 | 2001-04-26 | Advanced Cell Technology, Inc. | Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
US20030129745A1 (en) | 1999-10-28 | 2003-07-10 | Robl James M. | Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
AU1581001A (en) * | 1999-11-02 | 2001-05-14 | University Of Massachusetts | Use of haploid genomes for genetic diagnosis, modification and multiplication |
US6280718B1 (en) | 1999-11-08 | 2001-08-28 | Wisconsin Alumni Reasearch Foundation | Hematopoietic differentiation of human pluripotent embryonic stem cells |
EP1241935A2 (en) * | 1999-12-17 | 2002-09-25 | Gerald Schatten | Methods for producing transgenic animals |
AU2927501A (en) * | 2000-01-07 | 2001-07-24 | Oregon Health And Science University | Clonal propagation of primate offspring by embryo splitting |
US20050042749A1 (en) * | 2001-05-16 | 2005-02-24 | Carpenter Melissa K. | Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease |
US7455983B2 (en) * | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
US20030134413A1 (en) * | 2000-01-14 | 2003-07-17 | Rathjen Peter David | Cell production |
US6602711B1 (en) | 2000-02-21 | 2003-08-05 | Wisconsin Alumni Research Foundation | Method of making embryoid bodies from primate embryonic stem cells |
US7541184B2 (en) * | 2000-02-24 | 2009-06-02 | Invitrogen Corporation | Activation and expansion of cells |
US7439064B2 (en) | 2000-03-09 | 2008-10-21 | Wicell Research Institute, Inc. | Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium |
US7005252B1 (en) | 2000-03-09 | 2006-02-28 | Wisconsin Alumni Research Foundation | Serum free cultivation of primate embryonic stem cells |
US6619693B1 (en) * | 2000-03-10 | 2003-09-16 | Days Corporation | Apparatus and method for automatically leveling an object |
US7226057B2 (en) * | 2000-03-10 | 2007-06-05 | Days Corporation | Apparatus and method for automatically leveling an object |
JP4889902B2 (en) * | 2000-03-14 | 2012-03-07 | イーエス・セル・インターナショナル・プライヴェート・リミテッド | Method for producing human neural progenitor cells from human embryonic stem (hES) cells, method for producing neurons using the method, method for producing oligodendrocytes or astrocytes |
US6458589B1 (en) | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
US7776021B2 (en) | 2000-04-28 | 2010-08-17 | The Charles Stark Draper Laboratory | Micromachined bilayer unit for filtration of small molecules |
US6828145B2 (en) | 2000-05-10 | 2004-12-07 | Cedars-Sinai Medical Center | Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker |
NL1017973C2 (en) | 2000-05-10 | 2002-11-08 | Tristem Trading Cyprus Ltd | Design. |
US8273570B2 (en) * | 2000-05-16 | 2012-09-25 | Riken | Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells |
US7250294B2 (en) | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
AU6319901A (en) * | 2000-05-17 | 2001-11-26 | Geron Corp | Neural progenitor cell populations |
US7270998B2 (en) * | 2000-06-01 | 2007-09-18 | Japan Science And Technology Corporation | Method of concentrating and separating dopaminergic neurons |
CA2411849A1 (en) * | 2000-06-05 | 2001-12-13 | The Burnham Institute | Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
US20020012905A1 (en) | 2000-06-14 | 2002-01-31 | Snodgrass H. Ralph | Toxicity typing using liver stem cells |
JP5014535B2 (en) * | 2000-06-15 | 2012-08-29 | 田辺三菱製薬株式会社 | Cynomolgus monkey-derived embryonic stem cells |
WO2001096532A2 (en) * | 2000-06-15 | 2001-12-20 | Tanja Dominko | Method of generating pluripotent mammalian cells by fusion of a cytoplast fragment with a karyoplast |
CN100523174C (en) * | 2000-06-15 | 2009-08-05 | 田边三菱制药株式会社 | Monkey-origin embryonic stem cells |
EP1294855A4 (en) * | 2000-06-20 | 2004-09-15 | Es Cell Int Pte Ltd | Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists |
CA2417356A1 (en) * | 2000-08-01 | 2002-02-07 | Yissum Research Development Company | Directed differentiation of embryonic cells |
WO2002014469A2 (en) * | 2000-08-15 | 2002-02-21 | Geron Corporation | Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells |
US20040053869A1 (en) * | 2000-08-19 | 2004-03-18 | Peter Andrews | Stem cell differentiation |
US6921632B2 (en) | 2000-08-30 | 2005-07-26 | Maria Biotech Co., Ltd. | Human embryonic stem cells derived from frozen-thawed embryo |
US6534052B1 (en) | 2000-09-05 | 2003-03-18 | Yong-Fu Xiao | Cardiac function comprising implantation of embryonic stem cell in which differentiation has been initiated |
US6607720B1 (en) | 2000-09-05 | 2003-08-19 | Yong-Fu Xiao | Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction |
EP1323821A4 (en) * | 2000-09-14 | 2005-01-12 | Atsushi Yuki | Process for producing normal parenchymal cells, tissue or organ by bioincubator |
AUPR095200A0 (en) * | 2000-10-24 | 2000-11-16 | Bresagen Limited | Cell production |
WO2002038741A1 (en) * | 2000-11-09 | 2002-05-16 | Bresagen Limited | Cell reprogramming |
KR20040029311A (en) * | 2000-11-22 | 2004-04-06 | 제론 코포레이션 | Tolerizing allografts of pluripotent stem cells |
US6921665B2 (en) * | 2000-11-27 | 2005-07-26 | Roslin Institute (Edinburgh) | Selective antibody targeting of undifferentiated stem cells |
US6576464B2 (en) | 2000-11-27 | 2003-06-10 | Geron Corporation | Methods for providing differentiated stem cells |
US20030027331A1 (en) * | 2000-11-30 | 2003-02-06 | Yan Wen Liang | Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same |
AU2001297880B2 (en) * | 2000-11-30 | 2007-05-31 | Stemron Inc. | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
US20020068046A1 (en) * | 2000-12-04 | 2002-06-06 | Jianwu Dai | Use of stem cells derived from dermal skin |
AU2002251681A1 (en) * | 2000-12-05 | 2002-08-28 | Layton Bioscience Inc. | Production and use of dopaminergic cells to treat dopaminergic deficiencies |
KR20030088023A (en) | 2001-01-02 | 2003-11-15 | 스템론 인크. | A Method for Producing a Population of Homozygous Stem Cells Having a Pre-selected Immunotype and/or Genotype, Cells Suitable for Transplant Derived therefrom, and Materials and Methods Using Same |
CA2435826A1 (en) * | 2001-01-24 | 2002-08-01 | The Government Of The United States Of America | Differentiation of stem cells to pancreatic endocrine cells |
EP1367899A4 (en) * | 2001-02-14 | 2004-07-28 | Leo T Furcht | Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
AUPR349501A0 (en) * | 2001-03-02 | 2001-03-29 | Bresagen Limited | Cellular production control |
US7126039B2 (en) * | 2001-03-21 | 2006-10-24 | Geron Corporation | Animal tissue with carbohydrate antigens compatible for human transplantation |
CA2442177A1 (en) * | 2001-03-29 | 2002-10-10 | Ixion Biotechnology, Inc. | Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
US7838292B1 (en) | 2001-03-29 | 2010-11-23 | University Of Louisville Research Foundation, Inc. | Methods for obtaining adult human olfactory progenitor cells |
US20030082806A1 (en) * | 2001-04-27 | 2003-05-01 | Xcyte Therapies, Inc. | Maturation of antigen-presenting cells using activated T cells |
US20030211605A1 (en) * | 2001-05-01 | 2003-11-13 | Lee Sang-Hun | Derivation of midbrain dopaminergic neurons from embryonic stem cells |
US20050176665A1 (en) * | 2001-05-18 | 2005-08-11 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of hairless (HR) gene expression using short interfering nucleic acid (siNA) |
AU2002322379B2 (en) * | 2001-07-06 | 2007-02-15 | Asterias Biotherapeutics, Inc. | Mesenchymal cells and osteoblasts from human embryonic stem cell |
CN1543500B (en) * | 2001-07-12 | 2014-04-09 | 杰龙公司 | Cardiomyocyte precursors from human embryonic stem cells |
US7732199B2 (en) | 2001-07-12 | 2010-06-08 | Geron Corporation | Process for making transplantable cardiomyocytes from human embryonic stem cells |
US20030017587A1 (en) * | 2001-07-18 | 2003-01-23 | Rader William C. | Embryonic stem cells, clinical applications and methods for expanding in vitro |
DE10136719A1 (en) * | 2001-07-27 | 2003-02-20 | Georg S Wengler | Recovering omnipotent human embryonic stem cells, comprises separating them from a blastocyte which remains viable, useful for gene therapy especially autotransplants |
AU2002319780A1 (en) * | 2001-08-06 | 2003-02-24 | Bresagen, Ltd. | Alternative compositions and methods for the culture of stem cells |
US20030211603A1 (en) * | 2001-08-14 | 2003-11-13 | Earp David J. | Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells |
US20040092013A1 (en) * | 2001-08-14 | 2004-05-13 | Snyder Evan Y. | Method of treating alzheimer's disease with cell therapy |
CN1545549A (en) * | 2001-08-23 | 2004-11-10 | �Ϻ���ͨ��ѧ | Isolation of inner cell mass for the establishment of human embryonic stem cell (hESC) lines |
DE10144326B4 (en) * | 2001-09-10 | 2005-09-22 | Siemens Ag | Method and system for monitoring a tire air pressure |
US7588937B2 (en) * | 2001-10-03 | 2009-09-15 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
US6887706B2 (en) * | 2001-10-03 | 2005-05-03 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of transplantable neural precursor cells from primate embryonic stem cells |
US8153424B2 (en) * | 2001-10-03 | 2012-04-10 | Wisconsin Alumni Research Foundation | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
WO2003040319A2 (en) * | 2001-11-02 | 2003-05-15 | Wisconsin Alumni Research Foundation | Endothelial cells derived from primate embryonic stem cells |
US6759244B2 (en) * | 2001-11-08 | 2004-07-06 | Art Institute Of New York And New Jersey, Inc. | Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos |
US7491690B2 (en) * | 2001-11-14 | 2009-02-17 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
EP1442115B9 (en) * | 2001-11-15 | 2009-12-16 | Children's Medical Center Corporation | Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
JP5364224B2 (en) | 2001-12-07 | 2013-12-11 | ジェロン・コーポレーション | Hematopoietic cells derived from human embryonic stem cells |
IL162132A0 (en) * | 2001-12-07 | 2005-11-20 | Geron Corp | Chondrocyte precursors derived from human embryonic stem cells |
US20040224403A1 (en) * | 2001-12-07 | 2004-11-11 | Robarts Research Institute | Reconstituting hematopoietic cell function using human embryonic stem cells |
EP1463798A4 (en) * | 2001-12-07 | 2005-01-19 | Geron Corp | Islet cells from human embryonic stem cells |
US7799324B2 (en) * | 2001-12-07 | 2010-09-21 | Geron Corporation | Using undifferentiated embryonic stem cells to control the immune system |
US20030113910A1 (en) * | 2001-12-18 | 2003-06-19 | Mike Levanduski | Pluripotent stem cells derived without the use of embryos or fetal tissue |
GB0220145D0 (en) * | 2002-08-30 | 2002-10-09 | Thromb X Nv | Novel compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability |
ATE501167T1 (en) | 2001-12-21 | 2011-03-15 | Thrombogenics Nv | COMPOSITIONS FOR THE IN VITRO GENERATION AND CULTURE OF EMBRYONAL STEM CELL LINES WITH GERMANY TRANSMISSION ABILITY AND FOR THE CULTURE OF ADULT STEM CELLS |
CN1671835A (en) * | 2001-12-28 | 2005-09-21 | 塞拉提斯股份公司 | A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
US20040043482A1 (en) * | 2002-01-04 | 2004-03-04 | Kye-Hyung Paik | Method of producing stem cell lines |
US7190781B2 (en) * | 2002-01-04 | 2007-03-13 | Telefonaktiebolaget Lm Ericsson (Publ) | Message transfer part point code mapping method and node |
US20050170506A1 (en) * | 2002-01-16 | 2005-08-04 | Primegen Biotech Llc | Therapeutic reprogramming, hybrid stem cells and maturation |
US20050090004A1 (en) * | 2003-01-16 | 2005-04-28 | Sayre Chauncey B. | Stem cell maturation for all tissue lines |
US20030134422A1 (en) * | 2002-01-16 | 2003-07-17 | Sayre Chauncey Bigelow | Stem cell maturation for all tissue lines |
US20030162290A1 (en) * | 2002-01-25 | 2003-08-28 | Kazutomo Inoue | Method for inducing differentiation of embryonic stem cells into functioning cells |
CA2474968A1 (en) * | 2002-01-31 | 2003-08-07 | Asahi Techno Glass Corporation | Cryopreservation medium for primate embryo stem cells and cryopreservation method |
EP1472340A4 (en) * | 2002-02-05 | 2006-11-08 | Rappaport Family Inst For Res | Lineage committed stem cells selected for telomerase promoter activity |
US20050106724A1 (en) * | 2002-02-06 | 2005-05-19 | Joerg Schierholz | Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
WO2003070749A2 (en) * | 2002-02-15 | 2003-08-28 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
US7736892B2 (en) * | 2002-02-25 | 2010-06-15 | Kansas State University Research Foundation | Cultures, products and methods using umbilical cord matrix cells |
US20030161818A1 (en) * | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
US20060057657A1 (en) * | 2002-03-12 | 2006-03-16 | Oregon Health & Science University Technology & Research Collaborations | Stem cell selection and differentiation |
WO2003075648A1 (en) * | 2002-03-13 | 2003-09-18 | Fundacion Ivi Para El Estudio De La Reproduccion Humana (Fivier) | Method of producing cell lines |
EP1490506A4 (en) | 2002-03-15 | 2005-06-08 | Wicell Res Inst Inc | Method for generating primate trophoblasts |
EP1490486A4 (en) * | 2002-03-15 | 2006-05-03 | Wisconsin Alumni Res Found | Method of identifying genes controlling diferentiation |
GB0207440D0 (en) * | 2002-03-28 | 2002-05-08 | Ppl Therapeutics Scotland Ltd | Tolerogenic antigen-presenting cells |
US20040111285A1 (en) * | 2002-04-09 | 2004-06-10 | Mark Germain | Method for human pluripotent stem cells |
CA2484223A1 (en) * | 2002-04-25 | 2003-11-06 | Wisconsin Alumni Research Foundation | Use of human neural stem cells secreting gdnf for treatment of parkinson's and other neurodegenerative diseases |
US20030207448A1 (en) * | 2002-05-06 | 2003-11-06 | Revera Gregory Henry | Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo |
US6816665B2 (en) * | 2002-05-09 | 2004-11-09 | Lynx Photonic Networks Inc. | Constant power operation thermo-optic switch |
US20060003446A1 (en) | 2002-05-17 | 2006-01-05 | Gordon Keller | Mesoderm and definitive endoderm cell populations |
CA2684022C (en) * | 2002-05-17 | 2014-09-23 | Mount Sinai School Of Medicine Of New York University | Mesoderm and definitive endoderm cell populations |
CA2505598A1 (en) | 2002-05-24 | 2003-12-04 | Advanced Cell Technology, Inc. | A bank of stem cells for transplantation |
US7410797B2 (en) * | 2002-06-11 | 2008-08-12 | Ogle Roy C | Meningeal-derived stem cells |
US9321992B2 (en) * | 2002-06-14 | 2016-04-26 | Case Western Reserve University | Cell targeting methods and compositions |
US20050101014A1 (en) * | 2002-07-11 | 2005-05-12 | Keirstead Hans S. | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
US7285415B2 (en) * | 2002-07-11 | 2007-10-23 | The Regents Of The University Of California | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
US20110158966A1 (en) * | 2002-07-23 | 2011-06-30 | Judith Seligman | Stem cells characterized by expression of germline specific genes |
WO2007116408A2 (en) * | 2006-04-11 | 2007-10-18 | Nanodiagnostics Israel Ltd. | Pluripotent stem cells characterized by expression of germline specific genes |
CA2493768A1 (en) * | 2002-07-23 | 2004-01-29 | Nanodiagnostics, Inc. | Embryonic stem cell markers and uses thereof |
US7422736B2 (en) * | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
US8876532B2 (en) | 2002-07-31 | 2014-11-04 | Dentsply International Inc. | Bone repair putty |
US7462448B2 (en) * | 2002-08-02 | 2008-12-09 | Stratatech Corporation | Species specific DNA detection |
EP1534068A4 (en) * | 2002-08-08 | 2006-08-23 | Univ Georgia Res Found | Compositions and methods for neural differentiation of embryonic stem cells |
US20060110375A1 (en) * | 2002-08-09 | 2006-05-25 | Herbert Zech | Method for producing cell lines and organs by means of differentiable cells |
WO2004018628A2 (en) | 2002-08-21 | 2004-03-04 | Northwestern University | Charged peptide-amphiphile solutions & self-assembled peptide nanofiber networks formed therefrom |
CA2404540A1 (en) * | 2002-09-20 | 2004-03-20 | Institut Pasteur | A method for measuring a marker indicative of the exposure of a patient to nicotine; a kit for measuring such a marker |
AU2003276924A1 (en) * | 2002-09-25 | 2004-04-19 | Bresagen, Inc. | Compositions and methods for enrichment of neural stem cells using ceramide analogs |
US7267981B2 (en) * | 2002-10-07 | 2007-09-11 | Technion Research & Development Foundation Ltd. | Human foreskin fibroblasts for culturing ES cells |
CN1717478A (en) * | 2002-10-25 | 2006-01-04 | 湖南惠霖生命科技有限公司 | Be used for the feeder layer of hESC's vitro culture and the method for cultivating embryonic stem cell |
US7554021B2 (en) | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
AU2003298647A1 (en) | 2002-11-14 | 2004-06-15 | Claussen, Randal, C. | Synthesis and self-assembly of abc triblock bola peptide |
AU2003302701A1 (en) * | 2002-11-29 | 2004-06-23 | Technion Research And Development Foundation Ltd. | Method of dynamically culturing embryonic stem cells |
US20040110286A1 (en) * | 2002-12-06 | 2004-06-10 | The John P. Robarts Research Institute | Method for making hematopoietic cells |
CA2508880C (en) | 2002-12-16 | 2018-02-06 | Technion Research And Development Foundation Ltd. | Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same |
WO2004076624A2 (en) * | 2002-12-18 | 2004-09-10 | Bresagen, Inc. | Compositions and methods for neural cell production and stabilization |
WO2004065616A2 (en) | 2003-01-16 | 2004-08-05 | The General Hospital Corporation | Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications |
AU2004210853A1 (en) * | 2003-02-11 | 2004-08-26 | Northwestern University | Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
US7674620B2 (en) * | 2003-03-12 | 2010-03-09 | Reliance Life Sciences Pvt. Ltd. | Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
US7153650B2 (en) * | 2003-03-13 | 2006-12-26 | Geron Corporation | Marker system for preparing and characterizing high-quality human embryonic stem cells |
US20030224411A1 (en) * | 2003-03-13 | 2003-12-04 | Stanton Lawrence W. | Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
WO2004087885A2 (en) * | 2003-03-27 | 2004-10-14 | Ixion Biotechnology, Inc. | Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway |
JP4502317B2 (en) * | 2003-03-28 | 2010-07-14 | 独立行政法人農業生物資源研究所 | Method for selecting undifferentiated cells and use thereof |
US20040191839A1 (en) * | 2003-03-28 | 2004-09-30 | National Institute Of Agrobiological Sciences Japan | Methods for sorting undifferentiated cells and uses thereof |
JP2004298108A (en) * | 2003-03-31 | 2004-10-28 | Japan Science & Technology Agency | Method for producing lens cell, and lens cell obtained by the method |
AU2004227204B2 (en) | 2003-04-08 | 2010-06-03 | Yeda Research And Development Co. Ltd | Stem cells having increased sensitivity to SDF-1 and methods of generating and using same |
US20060037086A1 (en) * | 2003-04-09 | 2006-02-16 | Schatten Gerald P | Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals |
FR2853551B1 (en) | 2003-04-09 | 2006-08-04 | Lab Francais Du Fractionnement | STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM |
EP1615492A4 (en) * | 2003-04-09 | 2010-07-14 | Magee Womens Health Corp | Methods for correcting mitotic spindle defects associated with somatic cell nuclear transfer in animals |
IL155783A (en) | 2003-05-05 | 2010-11-30 | Technion Res & Dev Foundation | Multicellular systems of pluripotent human embryonic stem cells and cancer cells and uses thereof |
US7638328B2 (en) * | 2003-05-08 | 2009-12-29 | Cellartis Ab | Method for efficient transfer of human blastocyst-derived stem cells (hBS cells) from a feeder-supported to a feeder-free culture system, long-term propagation of hBS cells under feeder-free conditions and use of cultured hBS cells for applications in myocardial regeneration |
WO2004099395A2 (en) * | 2003-05-08 | 2004-11-18 | Cellartis Ab | A method for the generation of neural progenitor cells |
US20090203141A1 (en) * | 2003-05-15 | 2009-08-13 | Shi-Lung Lin | Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents |
US9567591B2 (en) | 2003-05-15 | 2017-02-14 | Mello Biotechnology, Inc. | Generation of human embryonic stem-like cells using intronic RNA |
US7960166B2 (en) | 2003-05-21 | 2011-06-14 | The General Hospital Corporation | Microfabricated compositions and processes for engineering tissues containing multiple cell types |
EP1702062A2 (en) * | 2003-06-11 | 2006-09-20 | Jan Remmereit | Differentiation of stem cells for therapeutic use |
WO2004108882A2 (en) * | 2003-06-11 | 2004-12-16 | Yeda Research And Development Co. Ltd. | Neural stem cells and methods of generating and utilizing same |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US7875273B2 (en) | 2004-12-23 | 2011-01-25 | Ethicon, Incorporated | Treatment of Parkinson's disease and related disorders using postpartum derived cells |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US8491883B2 (en) | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US7413734B2 (en) | 2003-06-27 | 2008-08-19 | Ethicon, Incorporated | Treatment of retinitis pigmentosa with human umbilical cord cells |
US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
US20050019907A1 (en) * | 2003-07-22 | 2005-01-27 | Santiago Munne | Obtaining normal disomic stem cells from chromosomally abnormal embryos |
US7674291B2 (en) | 2003-08-01 | 2010-03-09 | Stratatech Corporation | Human skin equivalents expressing exogenous polypeptides |
US7569385B2 (en) * | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
US7820439B2 (en) * | 2003-09-03 | 2010-10-26 | Reliance Life Sciences Pvt Ltd. | In vitro generation of GABAergic neurons from pluripotent stem cells |
US20050054100A1 (en) * | 2003-09-08 | 2005-03-10 | Rennard Stephen I. | Methods for fibroblast differentiation |
WO2005033297A1 (en) * | 2003-09-19 | 2005-04-14 | The Rockefeller University | Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells |
EP1677594B1 (en) * | 2003-10-09 | 2011-01-12 | Core Dynamics Limited | Method for freezing, thawing and transplantation of viable cartilage |
US20050100924A1 (en) * | 2003-11-06 | 2005-05-12 | National University Of Singapore | C/EBPalpha gene targeting constructs and uses thereof |
IL158868A0 (en) * | 2003-11-13 | 2004-05-12 | Yeda Res & Dev | Methods of generating and using stem cells enriched with immature primitive progenitor |
EP1530970A1 (en) * | 2003-11-13 | 2005-05-18 | Medizinische Hochschule Hannover | Composition and method for inducing immune tolerance towards cell, tissue and/or organ transplants |
WO2005052138A1 (en) * | 2003-11-19 | 2005-06-09 | Wisconsin Alumni Research Foundation | Cryopreservation of pluripotent stem cells |
US20050106725A1 (en) * | 2003-11-19 | 2005-05-19 | Palecek Sean P. | Method of reducing cell differentiation |
US20080220520A1 (en) * | 2003-11-19 | 2008-09-11 | Palecek Sean P | Cryopreservation of human embryonic stem cells in microwells |
US20080026460A1 (en) * | 2006-06-20 | 2008-01-31 | Palecek Sean P | Method for culturing stem cells |
US7790039B2 (en) * | 2003-11-24 | 2010-09-07 | Northwest Biotherapeutics, Inc. | Tangential flow filtration devices and methods for stem cell enrichment |
US7682828B2 (en) | 2003-11-26 | 2010-03-23 | Whitehead Institute For Biomedical Research | Methods for reprogramming somatic cells |
US20070269412A1 (en) * | 2003-12-02 | 2007-11-22 | Celavie Biosciences, Llc | Pluripotent cells |
CN101065478B (en) * | 2003-12-02 | 2012-07-04 | 塞拉维生物科学公司 | Compositions and methods for propagation of neural progenitor cells |
CN1905892A (en) * | 2003-12-05 | 2007-01-31 | 西北大学 | Self-assembling peptide amphiphiles and related methods for growth factor delivery |
MXPA06006387A (en) * | 2003-12-05 | 2006-09-04 | Univ Northwestern | Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof. |
TWI280280B (en) * | 2003-12-09 | 2007-05-01 | Ind Tech Res Inst | Culture system and method for expansion and undifferentiated growth of human embryonic stem cells |
US20060030042A1 (en) * | 2003-12-19 | 2006-02-09 | Ali Brivanlou | Maintenance of embryonic stem cells by the GSK-3 inhibitor 6-bromoindirubin-3'-oxime |
US7985585B2 (en) | 2004-07-09 | 2011-07-26 | Viacyte, Inc. | Preprimitive streak and mesendoderm cells |
US20050214257A1 (en) | 2003-12-23 | 2005-09-29 | Northwestern University | Compositions and methods for controlling stem cell and tumor cell differentiation, growth, and formation |
US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
DK2722387T3 (en) | 2003-12-23 | 2020-01-20 | Viacyte Inc | Definitely endoderm |
WO2007059007A2 (en) * | 2005-11-14 | 2007-05-24 | Cythera, Inc. | Markers of definitive endoderm |
US7625753B2 (en) * | 2003-12-23 | 2009-12-01 | Cythera, Inc. | Expansion of definitive endoderm cells |
US7541185B2 (en) * | 2003-12-23 | 2009-06-02 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
US20050266554A1 (en) * | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
WO2005065354A2 (en) * | 2003-12-31 | 2005-07-21 | The Burnham Institute | Defined media for pluripotent stem cell culture |
CA2552288C (en) | 2004-01-02 | 2015-02-24 | Advanced Cell Technology, Inc. | Novel culture systems for ex vivo development |
EP2319544A1 (en) | 2004-01-16 | 2011-05-11 | Carnegie Mellon University | Cellular labeling for nuclear magnetic resonance techniques |
US20080241107A1 (en) * | 2004-01-23 | 2008-10-02 | Copland Iii John A | Methods and Compositions For Preparing Pancreatic Insulin Secreting Cells |
US20050186672A1 (en) * | 2004-01-27 | 2005-08-25 | Reliance Life Sciences Pvt. Ltd. | Tissue system with undifferentiated stem cells derived from corneal limbus |
US8196416B2 (en) * | 2004-02-02 | 2012-06-12 | Core Dynamics Limited | Device for directional cooling of biological matter |
JP4777908B2 (en) * | 2004-02-02 | 2011-09-21 | コア・ダイナミクス・リミテッド | Biological materials and methods and solutions for storage of biological materials |
WO2005080551A2 (en) * | 2004-02-12 | 2005-09-01 | University Of Newcastle Upon Tyne | Stem cells |
US20060216821A1 (en) * | 2004-02-26 | 2006-09-28 | Reliance Life Sciences Pvt. Ltd. | Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof |
BRPI0506536C1 (en) * | 2004-02-26 | 2007-05-22 | Reliance Life Sciences Pvt Ltd | corneal limbus-derived dopaminergic neurons, isolation methods and uses |
US8187875B2 (en) | 2004-02-26 | 2012-05-29 | Reliance Life Sciences Pvt. Ltd. | Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof |
US20050214938A1 (en) * | 2004-03-26 | 2005-09-29 | Gold Joseph D | Cardiac bodies: clusters of spontaneously contracting cells for regenerating cardiac function |
US7452718B2 (en) * | 2004-03-26 | 2008-11-18 | Geron Corporation | Direct differentiation method for making cardiomyocytes from human embryonic stem cells |
CA2563518C (en) | 2004-04-23 | 2014-09-02 | Bioe, Inc. | Multi-lineage progenitor cells |
US7622108B2 (en) | 2004-04-23 | 2009-11-24 | Bioe, Inc. | Multi-lineage progenitor cells |
EP2377922B1 (en) | 2004-04-27 | 2020-04-08 | Viacyte, Inc. | PDX1 expressing endoderm |
EP1743023A1 (en) * | 2004-05-07 | 2007-01-17 | Wisconsin Alumni Research Foundation | Method of forming mesenchymal stem cells from embryonic stem cells |
JP5096148B2 (en) * | 2004-06-07 | 2012-12-12 | コア・ダイナミクス・リミテッド | Method for disinfecting biological samples |
CN103146649B (en) * | 2004-06-09 | 2018-05-22 | 爱丁堡大学管理处 | Neural stem cell |
US20060008451A1 (en) * | 2004-07-06 | 2006-01-12 | Michigan State University | In vivo methods for effecting tissue specific differentiation of embryonic stem cells |
CA2573354C (en) | 2004-07-09 | 2015-02-24 | Cythera, Inc. | Preprimitive streak and mesendoderm cells |
WO2006016999A1 (en) | 2004-07-09 | 2006-02-16 | Cythera, Inc. | Methods for identifying factors for differentiating definitive endoderm |
EP2267116B1 (en) | 2004-07-13 | 2017-05-31 | Asterias Biotherapeutics, Inc. | Growth medium for primate embryonic stem cells |
BRPI0513897A (en) * | 2004-07-29 | 2008-05-20 | Stem Cell Innovations Inc | stem cell differentiation |
WO2006016372A1 (en) * | 2004-08-12 | 2006-02-16 | I.M.T. Interface Multigrad Technology Ltd. | Method and apparatus for freezing or thawing of a biological material |
AU2005272681B2 (en) * | 2004-08-13 | 2009-11-19 | University Of Georgia Research Foundation, Inc. | Compositions and methods for self-renewal and differentiation in human embryonic stem cells |
EP1802744A4 (en) * | 2004-09-03 | 2008-06-18 | Agency Science Tech & Res | Method for maintaining pluripotency of stem/progenitor cells |
US20060177926A1 (en) * | 2004-09-07 | 2006-08-10 | Erika Sasaki | Common marmoset embryonic stem cell lines |
EP1819809A4 (en) * | 2004-09-21 | 2008-08-06 | Nvr Labs Ltd | Compositions and methods for stem cell expansion and differentiation |
ES2294650T3 (en) * | 2004-09-30 | 2008-04-01 | Reneuron Limited | CELLPHONE LINE. |
US20070077654A1 (en) * | 2004-11-01 | 2007-04-05 | Thomson James A | Platelets from stem cells |
AU2005304978A1 (en) | 2004-11-04 | 2006-05-18 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells |
US7893315B2 (en) * | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
WO2006053378A1 (en) * | 2004-11-16 | 2006-05-26 | Sydney Ifv Limited | Derivation and culture of human embryo-derived cells |
US7691629B2 (en) | 2004-11-17 | 2010-04-06 | Neuralstem, Inc. | Transplantation of human neural cells for treatment of neurodegenerative conditions |
US8017395B2 (en) | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
WO2006083394A2 (en) * | 2004-12-21 | 2006-08-10 | Ethicon, Inc. | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
US20060171930A1 (en) * | 2004-12-21 | 2006-08-03 | Agnieszka Seyda | Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same |
US20060153815A1 (en) * | 2004-12-21 | 2006-07-13 | Agnieszka Seyda | Tissue engineering devices for the repair and regeneration of tissue |
DE102004062184B4 (en) * | 2004-12-23 | 2013-08-01 | Wolfgang Würfel | Embryo-preserving production of pluripotent embryonic stem cells, stem cells thus obtained and use thereof |
CA2589041C (en) | 2004-12-23 | 2019-08-20 | Ethicon, Incorporated | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
AU2005322007B2 (en) | 2004-12-23 | 2011-06-30 | Viacyte, Inc. | Expansion of definitive endoderm cells |
US8597947B2 (en) * | 2004-12-29 | 2013-12-03 | Hadasit Medical Research Services & Development Limited | Undifferentiated stem cell culture systems |
EP1844136B1 (en) | 2004-12-29 | 2014-08-27 | Hadasit Medical Research Services And Development Ltd. | Stem cells culture systems |
US20060275899A1 (en) * | 2004-12-30 | 2006-12-07 | Stemlifeline, Inc. | Methods and compositions relating to embryonic stem cell lines |
EP1844139A1 (en) * | 2004-12-30 | 2007-10-17 | Stemlifeline, Inc. | Methods and systems relating to embryonic stem cell lines |
US20060247165A1 (en) * | 2005-01-21 | 2006-11-02 | Stupp Samuel I | Methods and compositions for encapsulation of cells |
US7022518B1 (en) * | 2005-01-31 | 2006-04-04 | Glen Feye | Apparatus and method for co-culturing of cells |
WO2006084314A1 (en) * | 2005-02-09 | 2006-08-17 | Australian Stem Cell Centre Limited | Stem cell populations and classification system |
EP1850661A2 (en) * | 2005-02-22 | 2007-11-07 | Interface Multigrad Technology (IMT) Ltd. | Preserved viable cartilage, method for its preservation, and system and devices used therefor |
MX2007010771A (en) * | 2005-03-04 | 2008-03-10 | Univ Northwestern | Angiogenic heparin binding peptide amphiphiles. |
US20070048865A1 (en) * | 2005-03-15 | 2007-03-01 | Kenzaburo Tani | Method for acceleration of stem cell differentiation |
ES2622508T3 (en) | 2005-03-17 | 2017-07-06 | Stratatech Corporation | Skin substitutes with enhanced purity |
US8012751B2 (en) * | 2005-03-31 | 2011-09-06 | Wisconsin Alumni Research Foundation | Differentiation of pluripotent embryonic stem cells |
WO2007021321A2 (en) * | 2005-04-01 | 2007-02-22 | Wake Forest University Health Sciences | Transcriptional profiling of stem cells and their multilineage differentiation |
US7811817B2 (en) * | 2005-05-17 | 2010-10-12 | Reliance Life Sciences Pvt. Ltd. | Establishment of a human embryonic stem cell line using mammalian cells |
AU2006202209B2 (en) * | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
AU2006255183B2 (en) * | 2005-06-08 | 2012-02-02 | Centocor, Inc. | A cellular therapy for ocular degeneration |
EP1910518B1 (en) | 2005-06-22 | 2019-05-08 | Asterias Biotherapeutics, Inc. | Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells |
GB2441488C (en) | 2005-06-22 | 2011-10-05 | Geron Corp | Suspension culture of human embryonic stem cells |
JP2008546417A (en) * | 2005-06-22 | 2008-12-25 | シーエックスアール バイオサイエンス リミテッド | Reporter hepatocytes and other cells for drug screening and toxicity testing |
US20060292694A1 (en) * | 2005-06-22 | 2006-12-28 | Roslin Institute | Reporter hepatocytes and other cells for drug screening and toxicity testing |
US20060292695A1 (en) * | 2005-06-22 | 2006-12-28 | Roslin Institute | Methods and kits for drug screening and toxicity testing using promoter-reporter cells derived from embryonic stem cells |
WO2007014373A2 (en) * | 2005-07-29 | 2007-02-01 | Stem Cell Innovations | Novel cells, compositions, and methods |
US8198085B2 (en) * | 2005-08-03 | 2012-06-12 | Core Dynamics Limited | Somatic cells for use in cell therapy |
US20090035257A1 (en) | 2005-08-25 | 2009-02-05 | Repair Technologies, Inc. | Devices, compositions and methods for the protection and repair of cells and tissues |
EP1962719A4 (en) | 2005-08-29 | 2011-05-04 | Technion Res And Dev Of Foundation Ltd | Media for culturing stem cells |
WO2008020815A1 (en) | 2006-08-15 | 2008-02-21 | Agency For Science, Technology And Research | Mesenchymal stem cell conditioned medium |
EP2796544B1 (en) | 2005-09-09 | 2019-04-03 | Duke University | Tissue engineering methods and compositions |
ES2687233T3 (en) | 2005-10-27 | 2018-10-24 | Viacyte, Inc. | Endoderm of the dorsal and ventral proximal intestine expressing PDX-1 |
US7413900B2 (en) * | 2005-10-31 | 2008-08-19 | President And Fellows Of Harvard College | Immortalized fibroblasts |
CA2626728A1 (en) | 2005-11-10 | 2007-05-24 | Genervon Biopharmaceuticals L.L.C. | Mntf differentiation and growth of stem cells |
US7521221B2 (en) * | 2005-11-21 | 2009-04-21 | Board Of Trustees Of The University Of Arknasas | Staphylococcus aureus strain CYL1892 |
WO2007067280A2 (en) | 2005-12-08 | 2007-06-14 | University Of Louisville Research Foundation, Inc. | Very small embryonic-like (vsel) stem cells and methods of isolating and using the same |
US9155762B2 (en) * | 2005-12-08 | 2015-10-13 | University Of Louisville Research Foundation, Inc. | Uses and isolation of stem cells from bone marrow |
US8278104B2 (en) * | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
US20090227032A1 (en) * | 2005-12-13 | 2009-09-10 | Kyoto University | Nuclear reprogramming factor and induced pluripotent stem cells |
US8129187B2 (en) * | 2005-12-13 | 2012-03-06 | Kyoto University | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 |
CN103773804A (en) * | 2005-12-13 | 2014-05-07 | 国立大学法人京都大学 | Nuclear reprogramming factor |
PL1971681T3 (en) | 2005-12-16 | 2018-01-31 | Depuy Synthes Products Inc | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
AU2006327073B2 (en) | 2005-12-19 | 2012-08-30 | Ethicon, Inc. | In vitro expansion of postpartum derived cells in roller bottles |
AU2006330409B2 (en) * | 2005-12-28 | 2012-07-19 | Ethicon, Incorporated | Treatment of peripheral vascular disease using postpartum-derived cells |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
US8153429B2 (en) | 2006-02-23 | 2012-04-10 | Viacyte, Inc. | Compositions and methods useful for culturing differentiable cells |
SG170068A1 (en) | 2006-03-02 | 2011-04-29 | Cythera Inc | Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production |
EP2522352B1 (en) | 2006-03-02 | 2017-01-11 | Agency for Science, Technology and Research | Methods for stem cells modulation |
US11254916B2 (en) | 2006-03-02 | 2022-02-22 | Viacyte, Inc. | Methods of making and using PDX1-positive pancreatic endoderm cells |
US7695965B2 (en) * | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
AU2007257594B2 (en) | 2006-03-07 | 2012-11-01 | Geeta Shroff | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation |
US20070269411A1 (en) * | 2006-03-10 | 2007-11-22 | Wei Sun | Porous silicon materials and devices |
SE1050445A1 (en) * | 2006-04-10 | 2010-05-04 | Wisconsin Alumni Res Found | Reagents and Methods for Use of Human Embryonic Stem Cells to Evaluate Toxicity of Pharmaceutical Compounds and Other Chemicals |
WO2008054509A2 (en) * | 2006-04-14 | 2008-05-08 | Celsense, Inc. | Methods for assessing cell labeling |
US8263043B2 (en) * | 2006-04-14 | 2012-09-11 | Carnegie Mellon University | Cellular labeling and quantification for nuclear magnetic resonance techniques |
EP2019858B1 (en) | 2006-04-17 | 2012-06-13 | BioE LLC | Differentiation of multi-lineage progenitor cells to respiratory epithelial cells |
ES2725601T3 (en) | 2006-04-28 | 2019-09-25 | Lifescan Inc | Differentiation of human embryonic stem cells |
US8741643B2 (en) | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
WO2007127454A2 (en) * | 2006-04-28 | 2007-11-08 | Cythera, Inc. | Hepatocyte lineage cells |
KR101234544B1 (en) * | 2006-04-28 | 2013-03-07 | 다이이찌 산쿄 가부시키가이샤 | Method for differentiation induction of myocardial cell from pluripotent stem cell |
EP2656832B1 (en) | 2006-05-11 | 2018-12-19 | Regenics AS | Compositions for use in wound healing |
WO2007139929A2 (en) | 2006-05-25 | 2007-12-06 | The Burnham Institute For Medical Research | Methods for culture and production of single cell populations of human embryonic stem cells |
CA2654196A1 (en) * | 2006-06-02 | 2007-12-13 | University Of Georgia Research Foundation, Inc. | Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems |
WO2007149182A2 (en) | 2006-06-19 | 2007-12-27 | Geron Corporation | Differentiation and enrichment of islet-like cells from human pluripotent stem cells |
US20080003676A1 (en) * | 2006-06-26 | 2008-01-03 | Millipore Corporation | Growth of embryonic stem cells |
CN101511307A (en) | 2006-07-24 | 2009-08-19 | 国际干细胞公司 | Synthetic cornea from retinal stem cells |
CA2661232A1 (en) * | 2006-08-31 | 2008-03-06 | The University Of Louisville Research Foundation, Inc. | Transcription factors for differentiation of adult human olfactory progenitor cells |
US20100323442A1 (en) * | 2006-10-17 | 2010-12-23 | Emmanuel Edward Baetge | Modulation of the phosphatidylinositol-3-kinase pathway in the differentiation of human embryonic stem cells |
WO2008066658A2 (en) * | 2006-11-03 | 2008-06-05 | The Trustees Of Princeton University | Engineered cellular pathways for programmed autoregulation of differentiation |
WO2008067142A2 (en) * | 2006-11-08 | 2008-06-05 | Wisconsin Alumni Research Foundation | In vitro differentiation of hematopoietic cells from primate embryonic stem cells |
CA2670497A1 (en) * | 2006-11-24 | 2008-05-29 | Regents Of The University Of Minnesota | Endodermal progenitor cells |
US7883698B2 (en) * | 2007-01-17 | 2011-02-08 | Maria Michejda | Isolation and preservation of fetal hematopoietic and mesencymal system cells from non-controversial materials and/or tissues resulting from miscarriages and methods of therapeutic use |
AU2008206884B2 (en) | 2007-01-18 | 2012-07-05 | Glykos Finland Oy | Novel methods and reagents directed to production of cells |
AU2008206885B2 (en) | 2007-01-18 | 2011-02-03 | Glykos Finland Oy | Novel carbohydrate from human cells and methods for analysis and modification thereof |
US8084023B2 (en) | 2007-01-22 | 2011-12-27 | The Board Of Trustees Of The University Of Arkansas | Maintenance and propagation of mesenchymal stem cells |
KR20090115142A (en) * | 2007-01-30 | 2009-11-04 | 유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 | Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells(mmc) |
US8097588B2 (en) * | 2007-02-08 | 2012-01-17 | Sanford-Burnham Medical Research Institute | Trophinin-binding peptides and uses thereof |
CN101679942A (en) | 2007-02-23 | 2010-03-24 | 先进细胞技术公司 | Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
WO2008118820A2 (en) | 2007-03-23 | 2008-10-02 | Wisconsin Alumni Research Foundation | Somatic cell reprogramming |
CA2678901C (en) * | 2007-03-26 | 2017-11-14 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods for modulating embryonic stem cell differentiation |
US20080267874A1 (en) * | 2007-03-28 | 2008-10-30 | The Buck Institute For Age Research | Targeted Neuronal And Glial Human Embryonic Stem Cell Line |
EP2626416A3 (en) * | 2007-04-07 | 2013-12-18 | The Whitehead Institute for Biomedical Research | Reprogramming of somatic cells |
US8076295B2 (en) * | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
EP3640326A1 (en) | 2007-04-18 | 2020-04-22 | Hadasit Medical Research Services & Development Limited | Stem cell-derived retinal pigment epithelial cells |
EP2154242B1 (en) * | 2007-06-07 | 2016-01-06 | Keiichi Fukuda | Method of inducing differentiation into myocardial cells using g-csf |
US9213999B2 (en) * | 2007-06-15 | 2015-12-15 | Kyoto University | Providing iPSCs to a customer |
JP2008307007A (en) * | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth |
DK3293256T3 (en) | 2007-06-29 | 2019-08-12 | Fujifilm Cellular Dynamics Inc | Automated method and apparatus for culturing embryonic stem cells |
US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
MX2010000348A (en) * | 2007-07-01 | 2010-04-12 | Lifescan Inc | Single pluripotent stem cell culture. |
WO2009009105A2 (en) * | 2007-07-10 | 2009-01-15 | Carnegie Mellon University | Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques |
EP3957716A1 (en) | 2007-07-18 | 2022-02-23 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
CA2693827A1 (en) * | 2007-07-25 | 2009-01-29 | Bioe, Inc. | Differentiation of multi-lineage progenitor cells to chondrocytes |
RU2473685C2 (en) * | 2007-07-31 | 2013-01-27 | Лайфскен, Инк. | Differentiation of human embryo stem cells |
WO2009048675A1 (en) | 2007-07-31 | 2009-04-16 | Lifescan, Inc. | Pluripotent stem cell differentiation by using human feeder cells |
CA2695321A1 (en) | 2007-08-16 | 2009-02-26 | Andreas Androutsellis-Theotokis | Methods for promoting stem cell proliferation and survival |
JP6151879B2 (en) | 2007-08-31 | 2017-06-21 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | Stimulation of the WNT pathway in reprogramming somatic cells |
US10925903B2 (en) | 2007-09-13 | 2021-02-23 | Reprobiogen Inc. | Use of cells derived from first trimester umbilical cord tissue |
US7695963B2 (en) | 2007-09-24 | 2010-04-13 | Cythera, Inc. | Methods for increasing definitive endoderm production |
US20110236971A2 (en) * | 2007-09-25 | 2011-09-29 | Maksym Vodyanyk | Generation of Clonal Mesenchymal Progenitors and Mesenchymal Stem Cell Lines Under Serum-Free Conditions |
BRPI0818183A2 (en) | 2007-10-05 | 2019-07-16 | Ethicon Inc | Renal tissue repair and regeneration using cells derived from human umbilical cord tissue |
US8623650B2 (en) | 2007-10-19 | 2014-01-07 | Viacyte, Inc. | Methods and compositions for feeder-free pluripotent stem cell media containing human serum |
EP2214497A4 (en) * | 2007-10-30 | 2010-11-24 | Univ Louisville Res Found | Uses and isolation of very small embryonic-like (vsel) stem cells |
WO2009070592A2 (en) * | 2007-11-27 | 2009-06-04 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
US8609413B2 (en) * | 2007-12-11 | 2013-12-17 | Research Development Foundation | Neurons, astrocytes and oligodendrocytes differentiated from a mammalian pluripotent or neural stem cells exposed to a pyridine deriviative |
US8236538B2 (en) | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
US20110111492A1 (en) | 2008-01-18 | 2011-05-12 | Regents Of The University Of Minnesota | Stem Cell Aggregates and Methods for Making and Using |
CN105331577A (en) | 2008-01-30 | 2016-02-17 | 阿斯特利亚斯生物治疗股份公司 | Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells |
US8241907B2 (en) * | 2008-01-30 | 2012-08-14 | Geron Corporation | Synthetic surfaces for culturing stem cell derived cardiomyocytes |
EP3095470A1 (en) | 2008-02-07 | 2016-11-23 | Shahar Cohen | Compartmental extract compositions for tissue engineering |
US20090202978A1 (en) * | 2008-02-13 | 2009-08-13 | Ginadi Shaham | Method and apparatus for freezing of a biological material |
BRPI0908033A2 (en) * | 2008-02-21 | 2015-08-04 | Centocor Ortho Biotech Inc | Surface modified plate method and compositions for cell adhesion, culture and detachment |
US20100087002A1 (en) * | 2008-02-21 | 2010-04-08 | Benjamin Fryer | Methods, Surface Modified Plates and Compositions for Cell Attachment, Cultivation and Detachment |
EP2100954A1 (en) | 2008-03-10 | 2009-09-16 | Assistance Publique - Hopitaux de Paris | Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications |
DE102008013854A1 (en) * | 2008-03-12 | 2009-09-24 | Siemens Aktiengesellschaft | Catheter and associated medical examination and treatment facility |
SG188918A1 (en) | 2008-03-17 | 2013-04-30 | Agency Science Tech & Res | |
JP5951254B2 (en) | 2008-03-17 | 2016-07-13 | ザ スクリプス リサーチ インスティテュート | A combination of chemical and genetic techniques to generate induced pluripotent stem cells |
SG10201610881UA (en) | 2008-03-27 | 2017-03-30 | Asterias Biotherapeutics Inc | Differentiation of primate pluripotent stem cells to hematopoietic lineage cells |
US8338170B2 (en) | 2008-04-21 | 2012-12-25 | Viacyte, Inc. | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
DK2283117T3 (en) | 2008-04-21 | 2014-01-20 | Viacyte Inc | PROCEDURE FOR CLEANING PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS |
US7939322B2 (en) | 2008-04-24 | 2011-05-10 | Centocor Ortho Biotech Inc. | Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm |
US8623648B2 (en) | 2008-04-24 | 2014-01-07 | Janssen Biotech, Inc. | Treatment of pluripotent cells |
EP2274430B1 (en) * | 2008-04-30 | 2016-09-14 | SanBio, Inc. | Neural regenerating cells with alterations in dna methylation |
US20100279404A1 (en) * | 2008-05-02 | 2010-11-04 | Shinya Yamanaka | Method of nuclear reprogramming |
CA2723171C (en) * | 2008-05-02 | 2018-03-27 | Celsense, Inc. | Emulsion compositions and methods for nuclear magnetic resonance and other imaging |
US9102920B2 (en) * | 2008-05-06 | 2015-08-11 | Agency For Science, Technology And Research | Method of effecting de-differentiation of a cell |
US9394538B2 (en) | 2008-05-07 | 2016-07-19 | Shi-Lung Lin | Development of universal cancer drugs and vaccines |
DK2296676T3 (en) | 2008-05-09 | 2016-12-19 | Regenics As | cellular extracts |
US20090280096A1 (en) * | 2008-05-09 | 2009-11-12 | Atsushi Kubo | Pancreatic endocrine progenitor cells derived from pluripotent stem cells |
EP2300023A2 (en) * | 2008-05-16 | 2011-03-30 | Genelux Corporation | Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
CA2724839A1 (en) * | 2008-05-21 | 2009-11-26 | Bioe Llc | Differentiation of multi-lineage progenitor cells to pancreatic cells |
DK2993226T3 (en) | 2008-06-03 | 2021-02-22 | Viacyte Inc | GROWTH FACTORS FOR THE PRODUCTION OF A DEFINITIVE ENDODERM |
US20090298178A1 (en) * | 2008-06-03 | 2009-12-03 | D Amour Kevin Allen | Growth factors for production of definitive endoderm |
WO2009149233A1 (en) | 2008-06-04 | 2009-12-10 | Stem Cell Products, Inc. | Methods for the production of ips cells using non-viral approach |
CA3060170A1 (en) | 2008-06-13 | 2009-12-17 | Whitehead Institute For Biomedical Research | Programming and reprogramming of cells |
US8871900B2 (en) | 2008-06-16 | 2014-10-28 | University Of Rochester | Fibroblast growth factor (FGF) analogs and uses thereof |
WO2010008486A2 (en) | 2008-06-24 | 2010-01-21 | Parkinsons Institute | Pluripotent cell lines and methods of use thereof |
CN102159703B (en) | 2008-06-30 | 2015-11-25 | 森托科尔奥索生物科技公司 | The differentiation of multipotential stem cell |
US20110305672A1 (en) | 2008-07-25 | 2011-12-15 | University Of Georgia Research Foundation, Inc. | COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME |
US20100028307A1 (en) * | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
KR101712085B1 (en) | 2008-10-31 | 2017-03-03 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
CN107435038B (en) | 2008-10-31 | 2021-07-09 | 詹森生物科技公司 | Differentiation of human embryonic stem cells into the pancreatic endocrine lineage |
NZ592622A (en) | 2008-11-04 | 2012-10-26 | Viacyte Inc | Stem cell aggregate suspension compositions and methods for differentiation thereof |
US8956867B2 (en) * | 2008-11-07 | 2015-02-17 | Wisconsin Alumni Research Foundation | Method for culturing stem cells |
EP2356227B1 (en) | 2008-11-14 | 2018-03-28 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
AU2009316580B2 (en) | 2008-11-20 | 2016-04-14 | Janssen Biotech, Inc. | Pluripotent stem cell culture on micro-carriers |
CA2744227C (en) * | 2008-11-20 | 2018-10-02 | Centocor Ortho Biotech Inc. | Methods and compositions for cell attachment and cultivation on planar substrates |
EP3312269A1 (en) | 2008-12-17 | 2018-04-25 | The Scripps Research Institute | Generation and maintenance of stem cells |
EP2379088B1 (en) | 2008-12-19 | 2018-02-28 | DePuy Synthes Products, Inc. | Treatment of lung and pulmonary diseases and disorders |
AU2009327383B2 (en) * | 2008-12-19 | 2014-08-28 | DePuy Synthes Products, LLC | Regeneration and repair of neural tissue following injury |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
AU2009327382B2 (en) * | 2008-12-19 | 2014-07-17 | DePuy Synthes Products, LLC | Umbilical cord tissue derived cells for treating neuropathic pain and spasticity |
WO2010075500A1 (en) | 2008-12-23 | 2010-07-01 | Stemcells California, Inc | Target populations of oligodendrocyte precursor cells and methods of making and using same |
CA2787708A1 (en) | 2009-01-22 | 2010-07-29 | Iti Scotland Limited | Stem cell culture methods |
US20100209399A1 (en) * | 2009-02-13 | 2010-08-19 | Celavie Biosciences, Llc | Brain-derived stem cells for repair of musculoskeletal system in vertebrate subjects |
EP2233566A1 (en) | 2009-03-17 | 2010-09-29 | Vrije Universiteit Brussel | Generation of pancreatic progenitor cells |
JP5908394B2 (en) | 2009-03-26 | 2016-04-26 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | Human umbilical cord tissue cells as a therapy for Alzheimer's disease |
GB0906424D0 (en) | 2009-04-09 | 2009-05-20 | Antoxis Ltd | Use of compounds for differentiation of cells |
EP2419116A1 (en) * | 2009-04-13 | 2012-02-22 | North Western University | Novel peptide-based scaffolds for cartilage regeneration and methods for their use |
WO2010124142A2 (en) | 2009-04-22 | 2010-10-28 | Cythera, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
US9109245B2 (en) | 2009-04-22 | 2015-08-18 | Viacyte, Inc. | Cell compositions derived from dedifferentiated reprogrammed cells |
WO2010144696A1 (en) | 2009-06-11 | 2010-12-16 | Burnham Institute For Medical Research | Directed differentiation of stem cells |
US8193235B2 (en) * | 2009-06-12 | 2012-06-05 | University Of Kansas | Compositions and methods for establishing and maintaining stem cells in an undifferentiated state |
KR20120065966A (en) | 2009-06-12 | 2012-06-21 | 난양 폴리테크닉 | Novel uses |
GB0911060D0 (en) | 2009-06-26 | 2009-08-12 | Ge Healthcare Uk Ltd | Methods for predicting the toxicity of a chemical |
WO2011005326A1 (en) | 2009-07-09 | 2011-01-13 | Massachusetts Institute Of Technology | Methods and compositions for increased safety of stem cell-derived populations |
RU2540016C2 (en) | 2009-07-20 | 2015-01-27 | Янссен Байотек, Инк. | Differentiating human embryonic stem cells |
WO2011011300A2 (en) | 2009-07-20 | 2011-01-27 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells |
MX340952B (en) * | 2009-07-20 | 2016-07-29 | Janssen Biotech Inc | Differentiation of human embryonic stem cells. |
CN102625829B (en) | 2009-07-21 | 2015-05-06 | Abt控股公司 | Use of stem cells to reduce leukocyte extravasation |
ES2690199T3 (en) | 2009-07-21 | 2018-11-19 | Abt Holding Company | Use of stem cells to reduce leukocyte extravasation |
AU2010279572B2 (en) | 2009-08-03 | 2017-02-02 | Recombinetics, Inc. | Methods and compositions for targeted gene modification |
CA2770753C (en) | 2009-08-12 | 2019-01-15 | Kyoto University | Method for inducing differentiation of pluripotent stem cells into neural precursor cells |
EP2467470A2 (en) | 2009-08-17 | 2012-06-27 | Technion Research & Development Foundation Ltd. | Pericyte progenitor cells and methods of generating and using same |
ES2500057T3 (en) | 2009-08-22 | 2014-09-29 | The Board Of Trustees Of The University Of The Leland Stanford Junior University | Obtaining images and evaluation of embryos, oocytes and stem cells |
CA2772619C (en) | 2009-09-04 | 2019-07-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for enhancing genome stability and telomere elongation in embryonic stem cells |
ES2938049T3 (en) | 2009-10-16 | 2023-04-04 | Scripps Research Inst | Induction of stem cells |
AU2010315712B2 (en) | 2009-10-19 | 2014-04-17 | FUJIFILM Cellular Dynamics, Inc. | Cardiomyocyte production |
BR112012010136A2 (en) * | 2009-10-29 | 2015-09-15 | Janssen Biotech Inc | pluripotent stem cells |
EP2498796B1 (en) | 2009-11-09 | 2017-12-27 | AAL Scientifics, Inc. | Treatment of heart disease |
EP2499236B1 (en) | 2009-11-12 | 2020-01-01 | Technion Research & Development Foundation Ltd. | Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state |
KR20120093407A (en) * | 2009-12-02 | 2012-08-22 | 리서치 디벨럽먼트 파운데이션 | Selection of stem cell clones with defined differentiation capabilities |
FI20096288A0 (en) | 2009-12-04 | 2009-12-04 | Kristiina Rajala | Formulations and Methods for Culturing Stem Cells |
EP2513297B1 (en) | 2009-12-18 | 2016-09-21 | Shanghai iCell Biotechnology Co., Ltd. | Materials and methods for generating pluripotent stem cells |
RU2586506C2 (en) | 2009-12-23 | 2016-06-10 | Янссен Байотек, Инк. | Differentiation of human embryonic stem cells |
SG10201408552YA (en) | 2009-12-23 | 2015-02-27 | Janssen Biotech Inc | Differentiation of human embryonic stem cells |
WO2011091945A1 (en) | 2010-01-26 | 2011-08-04 | Université Libre de Bruxelles | Tools for isolating and following cardiovascular progenitor cells |
US8778416B2 (en) | 2010-02-10 | 2014-07-15 | Nayacure Therapeutics Ltd. | Pharmaceutical compositions and methods for the treatment and prevention of cancer |
WO2011106521A1 (en) | 2010-02-25 | 2011-09-01 | Abt Holding Company | Modulation of macrophage activation |
KR101900507B1 (en) | 2010-02-25 | 2018-09-19 | 에이비티 홀딩 컴퍼니 | Modulation of angiogenesis |
RU2607380C2 (en) | 2010-03-01 | 2017-01-10 | Янссен Байотек, Инк. | Methods of purifying cells, derived from pluripotent stem cells |
US8662085B2 (en) * | 2010-03-02 | 2014-03-04 | Siemens Aktiengesellschaft | Magnetic nanoparticle and group of nanoparticles |
US8703424B2 (en) | 2010-03-22 | 2014-04-22 | Stemina Biomarker Discovery, Inc. | Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomics |
CN102906248A (en) | 2010-03-25 | 2013-01-30 | 国际干细胞公司 | Method of altering differentiative state of cell and compositions thereof |
JP5909482B2 (en) | 2010-03-31 | 2016-04-26 | ザ スクリプス リサーチ インスティテュート | Cell reprogramming |
CA2828315A1 (en) | 2010-04-08 | 2011-10-13 | The University Court Of The University Of Edinburgh | Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof |
US8927274B2 (en) | 2010-04-12 | 2015-01-06 | Technion Research & Development Foundation Limited | Populations of pancreatic progenitor cells and methods of isolating and using same |
WO2011133661A2 (en) | 2010-04-21 | 2011-10-27 | Research Development Foundation | Methods and compositions related to dopaminergic neuronal cells |
JP5841322B2 (en) | 2010-04-22 | 2016-01-13 | オレゴン ヘルス アンド サイエンス ユニバーシティ | Fumaryl acetoacetate hydrolase (FAH) deficient pig and use thereof |
HUE040278T2 (en) | 2010-04-23 | 2019-02-28 | Cold Spring Harbor Laboratory | NOVEL STRUCTURALLY DESIGNED shRNAs |
CA2798137C (en) | 2010-05-06 | 2016-06-28 | Regenics As | Use of fish egg extracts for cellular rejuvenation |
CN102242146B (en) * | 2010-05-10 | 2015-11-25 | 高丽大学校产学协力团 | Composition and the method with its generation generate induced pluripotent stem cells |
SG185511A1 (en) | 2010-05-12 | 2012-12-28 | Centocor Ortho Biotech Inc | Differentiation of human embryonic stem cells |
CA2798895A1 (en) | 2010-05-12 | 2011-11-17 | Abt Holding Company | Modulation of splenocytes in cell therapy |
WO2011159726A2 (en) | 2010-06-14 | 2011-12-22 | The Scripps Research Institute | Reprogramming of cells to a new fate |
US9090878B2 (en) | 2010-06-17 | 2015-07-28 | Katholieke Universiteit Leuven | Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells |
EP2582792B1 (en) | 2010-06-18 | 2018-10-31 | FUJIFILM Cellular Dynamics, Inc. | Cardiomyocyte medium with dialyzed serum |
JP6660080B2 (en) | 2010-07-01 | 2020-03-04 | リジェネレイティブ リサーチ ファウンデーション | Undifferentiated cell culture method using sustained release composition |
CA2804595C (en) | 2010-07-07 | 2018-11-13 | Cellular Dynamics International, Inc. | Endothelial cell production by programming |
US8808687B2 (en) | 2010-07-12 | 2014-08-19 | Mark Humayun | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
EP2596096B1 (en) | 2010-07-21 | 2018-01-31 | Kyoto University | Method for inducing differentiation of human pluripotent stem cell into intermediate mesoderm cell |
CA2843050A1 (en) | 2010-07-26 | 2012-02-02 | The University Of Manchester | Targeted differentiation of stem cells |
WO2012014207A2 (en) * | 2010-07-27 | 2012-02-02 | Technion Research & Development Foundation Ltd. | Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles |
US9144585B2 (en) | 2010-07-27 | 2015-09-29 | Technion Research & Development Foundation Limited | Isolated mesenchymal progenitor cells and extracellular matrix produced thereby |
KR101765980B1 (en) | 2010-07-28 | 2017-08-07 | 뉴럴스템, 인크. | Methods for treating and/or reversing neurodegenerative diseases and/or disorders |
SG10201506264QA (en) | 2010-08-12 | 2015-09-29 | Janssen Biotech Inc | Treatment of diabetes with pancreatic endocrine precursor cells |
CA2838330C (en) | 2010-08-23 | 2021-01-26 | President And Fellows Of Harvard College | Optogenetic probes for measuring membrane potential |
US8609406B2 (en) | 2010-08-24 | 2013-12-17 | Regents Of The University Of Minnesota | Non-static suspension culture of cell aggregates |
KR101836855B1 (en) | 2010-08-31 | 2018-04-19 | 얀센 바이오테크 인코포레이티드 | Differentiation of pluripotent stem cells |
EP3372672A1 (en) | 2010-08-31 | 2018-09-12 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
KR101836850B1 (en) | 2010-08-31 | 2018-03-09 | 얀센 바이오테크 인코포레이티드 | Differentiation of human embryonic stem cells |
JP5986570B2 (en) | 2010-09-01 | 2016-09-06 | トーマス・ジェファーソン・ユニバーシティThomas Jefferson University | Compositions and methods for muscle repair and regeneration |
EP2614145B1 (en) | 2010-09-07 | 2020-12-02 | The Board of Regents of The University of Texas System | Tissue-specific differentiation matrices and uses thereof |
JP6283223B2 (en) | 2010-09-07 | 2018-02-21 | テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド | Novel method and culture medium for culturing pluripotent stem cells |
CN103459611B (en) | 2010-09-17 | 2016-11-02 | 哈佛大学校长及研究员协会 | The functional genomics research that effectiveness and the safety of pluripotent stem cell are characterized |
AU2011308567B2 (en) | 2010-10-01 | 2015-09-03 | Fundacion Centro Nacional De Investigaciones Oncologicas, Carlos Iii | Manipulation of stem cell function by p53 isoforms |
US9677042B2 (en) | 2010-10-08 | 2017-06-13 | Terumo Bct, Inc. | Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
WO2012054896A1 (en) | 2010-10-22 | 2012-04-26 | Biotime Inc. | Methods of modifying transcriptional regulatory networks in stem cells |
KR20200113286A (en) | 2010-12-22 | 2020-10-06 | 페이트 세러퓨틱스, 인코포레이티드 | Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs |
US20130280804A1 (en) | 2010-12-31 | 2013-10-24 | Stephen Dalton | Differentiation of human pluripotent stem cells to multipotent neural crest cells |
PL2667878T3 (en) | 2011-01-25 | 2016-10-31 | Compositions and methods for cell transplantation | |
US9102914B2 (en) | 2011-02-03 | 2015-08-11 | Empire Technology Development Llc | 3D trophoblast matrix for preparing organ-specific stem cells |
US9574179B2 (en) | 2011-02-08 | 2017-02-21 | Cellular Dynamics International, Inc. | Hematopoietic precursor cell production by programming |
WO2012115276A1 (en) | 2011-02-23 | 2012-08-30 | Kyoto University | Method for producing dendritic cells from pluripotent stem cells |
CN103460038A (en) | 2011-02-23 | 2013-12-18 | 里兰斯坦福初级大学理事会 | Methods of detecting aneuploidy in human embryos |
WO2012148549A1 (en) | 2011-02-25 | 2012-11-01 | Benaroya Research Institute | Detection of an immune response |
KR102351944B1 (en) | 2011-02-28 | 2022-01-18 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Cell culture system |
WO2012121971A2 (en) | 2011-03-04 | 2012-09-13 | The Regents Of The University Of California | Locally released growth factors to mediate motor recovery after stroke |
CA2829804A1 (en) | 2011-03-29 | 2012-10-04 | Geron Corporation | Enriched populations of cardiomyocyte lineage cells from pluripotent stem cells |
JP5840855B2 (en) | 2011-03-30 | 2016-01-06 | 学校法人東京女子医科大学 | Method for producing myocardial sheet from embryonic stem cells |
CA2831609C (en) | 2011-03-30 | 2019-06-11 | Cellular Dynamics International, Inc. | Priming of pluripotent stem cells for neural differentiation |
CN106692193B (en) | 2011-04-06 | 2021-01-05 | 桑比欧公司 | Methods and compositions for modulating peripheral immune function |
JP5745919B2 (en) * | 2011-04-28 | 2015-07-08 | 浜松ホトニクス株式会社 | Cell analysis method, cell analysis apparatus, and cell analysis program |
WO2012149468A2 (en) | 2011-04-29 | 2012-11-01 | University Of Southern California | Instruments and methods for the implantation of cell-seeded substrates |
US8877489B2 (en) | 2011-12-05 | 2014-11-04 | California Institute Of Technology | Ultrathin parylene-C semipermeable membranes for biomedical applications |
SG10201914092XA (en) | 2011-06-06 | 2020-03-30 | ReGenesys BVBA | Expansion of stem cells in hollow fiber bioreactors |
GB201110331D0 (en) | 2011-06-16 | 2011-08-03 | Isis Innovation | Method of cryopreserving pluripotent stem cells |
WO2013010045A1 (en) | 2011-07-12 | 2013-01-17 | Biotime Inc. | Novel methods and formulations for orthopedic cell therapy |
WO2013010965A1 (en) | 2011-07-15 | 2013-01-24 | Universite Libre De Bruxelles | Generation of mesodermal cells from pluripotent stem cells |
DK2737056T3 (en) | 2011-07-29 | 2018-05-22 | Cellular Dynamics Int Inc | Metabolic maturation in stem cell-derived tissue cells |
US9499793B2 (en) | 2011-08-09 | 2016-11-22 | Yeda Research And Development Co. Ltd. | Downregulation of miR-7 for promotion of beta cell differentiation and insulin production |
EP2747551B1 (en) | 2011-08-26 | 2020-02-12 | Yecuris Corporation | Fumarylacetoacetate hydrolase (fah)-deficient and immunodeficient rats and uses thereof |
US20140271578A1 (en) | 2011-09-30 | 2014-09-18 | University Of Miami | Renal stem cells isolated from kidney |
GB201117469D0 (en) | 2011-10-10 | 2011-11-23 | Cell Guidance Systems Ltd | Culture media for pluripotent stem cells |
EP2770051B1 (en) | 2011-10-21 | 2017-09-27 | ARKRAY, Inc. | Method for culturing pluripotency-maintained singly dispersed cells by means of laminar flow |
GB201119335D0 (en) | 2011-11-09 | 2011-12-21 | Univ Leuven Kath | Hepatitis virus infectable stem cells |
EP2594635A1 (en) | 2011-11-18 | 2013-05-22 | Univercell Biosolutions | Method for generating primate cardiovascular progenitor cells for clinical and drug cells testing use from primate embryonic stem cells or embryonic-like state cells, and their applications |
WO2013077423A1 (en) | 2011-11-25 | 2013-05-30 | 国立大学法人京都大学 | Method for culturing pluripotent stem cell |
US10238755B2 (en) | 2011-11-30 | 2019-03-26 | The Wistar Institute Of Anatomy And Biology | Methods and compositions for regulation of cell aging, carcinogenesis and reprogramming |
EP2785829B1 (en) | 2011-12-01 | 2019-10-16 | New York Stem Cell Foundation, Inc. | Automated system for producing induced pluripotent stem cells or differentiated cells |
US20150004144A1 (en) | 2011-12-02 | 2015-01-01 | The General Hospital Corporation | Differentiation into brown adipocytes |
EP2788033B1 (en) | 2011-12-05 | 2017-05-31 | Factor Bioscience Inc. | Methods and products for transfecting cells |
US8497124B2 (en) | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
US9248013B2 (en) | 2011-12-05 | 2016-02-02 | California Institute Of Technology | 3-Dimensional parylene scaffold cage |
JP6143268B2 (en) | 2011-12-19 | 2017-06-07 | 国立大学法人京都大学 | Method for inducing differentiation from human pluripotent stem cells to intermediate mesoderm cells |
JP6441080B2 (en) | 2011-12-22 | 2018-12-19 | ヤンセン バイオテツク,インコーポレーテツド | Differentiation of human embryonic stem cells into single hormone insulin-positive cells |
WO2013096686A1 (en) | 2011-12-23 | 2013-06-27 | Advanced Technologies And Regenerative Medicine, Llc | Detection of human umbilical cord tissue-derived cells |
EP2615176A1 (en) | 2012-01-11 | 2013-07-17 | Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe | Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells |
WO2013106677A1 (en) | 2012-01-13 | 2013-07-18 | The General Hospital Corporation | Isolated human lung progenitor cells and uses thereof |
ES2726802T3 (en) | 2012-01-25 | 2019-10-09 | Univ Catholique Louvain | Compositions and methods for cell transplantation |
EP2809152B1 (en) | 2012-02-01 | 2019-11-20 | Nayacure Therapeutics Ltd | Method for inducing immune tolerance to organ transplants |
WO2013124816A2 (en) | 2012-02-22 | 2013-08-29 | Brainstem Biotec Ltd. | Generation of neural stem cells and motor neurons |
US9434920B2 (en) | 2012-03-07 | 2016-09-06 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
WO2013151186A1 (en) | 2012-04-06 | 2013-10-10 | 国立大学法人京都大学 | Method for inducing erythropoietin-producing cell |
AU2013251749B2 (en) | 2012-04-24 | 2019-01-17 | International Stem Cell Corporation | Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells |
SG11201407768QA (en) | 2012-04-24 | 2015-01-29 | Brigham & Womens Hospital | Generating pluripotent cells de novo |
US20150104430A1 (en) | 2012-04-30 | 2015-04-16 | University Health Network | Methods and Compositions for Generating Pancreatic Progenitors and Functional Beta Cells from hPSCs |
JP5432322B2 (en) | 2012-05-08 | 2014-03-05 | 株式会社大塚製薬工場 | Mammalian cell suspension for prevention of pulmonary embolism containing trehalose |
HUE043861T2 (en) | 2012-05-25 | 2019-09-30 | Univ California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
CA2875038A1 (en) | 2012-05-31 | 2013-12-05 | Auxogyn, Inc. | In vitro embryo blastocyst prediction methods |
CN108103006A (en) | 2012-06-08 | 2018-06-01 | 詹森生物科技公司 | Differentiation of the human embryo stem cell to pancreatic endocrine cell |
KR102055438B1 (en) | 2012-07-31 | 2019-12-19 | 에이지엑스 쎄라퓨틱스, 인크. | Hla g-modified cells and methods |
JP2015526469A (en) | 2012-08-20 | 2015-09-10 | ボリス, マルコシアンMarkosian, Boris | Placental vaccination therapy for cancer |
US10724005B2 (en) | 2012-09-28 | 2020-07-28 | Scripps Health | Methods of differentiating stem cells into chondrocytes |
AU2013237760A1 (en) | 2012-10-08 | 2014-04-24 | Biotime, Inc. | Differentiated progeny of clonal progenitor cell lines |
WO2014070796A1 (en) | 2012-10-29 | 2014-05-08 | Scripps Health | Methods of transplanting chondrocytes |
JP6399558B2 (en) | 2012-10-29 | 2018-10-03 | スクリップス ヘルス | Method for producing pluripotent stem cells from chondrocytes |
AU2013337651B2 (en) | 2012-11-01 | 2018-12-13 | Factor Bioscience Inc. | Methods and products for expressing proteins in cells |
JP6339581B2 (en) | 2012-11-02 | 2018-06-06 | ステミナ バイオマーカー ディスカバリー, インコーポレイテッド | Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomic ratios |
AU2013248265B2 (en) | 2012-11-08 | 2018-11-01 | Viacyte, Inc. | Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof |
CA2894448C (en) | 2012-12-10 | 2019-09-17 | Regenics As | Use of cellular extracts for skin rejuvenation |
EP2938721B1 (en) | 2012-12-28 | 2019-10-16 | Kyoto University | Method for inducing astrocytes |
US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
MX2015008578A (en) | 2012-12-31 | 2015-09-07 | Janssen Biotech Inc | Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators. |
AU2013370228B2 (en) | 2012-12-31 | 2018-10-18 | Janssen Biotech, Inc. | Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells |
AU2013368221B2 (en) | 2012-12-31 | 2018-11-01 | Janssen Biotech, Inc. | Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells |
EP2950726B1 (en) | 2013-02-01 | 2019-10-23 | Ares Trading S.A. | Abnormal syngamy phenotypes observed with time lapse imaging for early identification of embryos with lower developmental potential |
JP6495658B2 (en) | 2013-02-08 | 2019-04-03 | 国立大学法人京都大学 | Method for producing megakaryocytes and platelets |
JP2016508520A (en) | 2013-02-15 | 2016-03-22 | インターナショナル ステム セル コーポレイション | Use of neurons derived from human pluripotent stem cells for the treatment of neurodegenerative diseases |
CA2901747A1 (en) | 2013-02-22 | 2014-08-28 | Cellular Dynamics International, Inc. | Hepatocyte production via forward programming by combined genetic and chemical engineering |
JP6292415B2 (en) | 2013-03-06 | 2018-03-14 | 国立大学法人京都大学 | Pluripotent stem cell culture system and pluripotent stem cell passage method |
WO2014143383A1 (en) | 2013-03-13 | 2014-09-18 | Agilent Technologies, Inc. | Transposome tethered to a gene delivery vehicle |
US8859286B2 (en) | 2013-03-14 | 2014-10-14 | Viacyte, Inc. | In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells |
CA2899507A1 (en) | 2013-03-14 | 2014-09-25 | The Regents Of The University Of California | In vitro production of medial ganglionic eminence precursor cells |
CN105247070A (en) | 2013-03-15 | 2016-01-13 | 怀特黑德生物医学研究院 | Cellular discovery platform for neurodegenerative diseases |
SG11201507829SA (en) | 2013-03-21 | 2015-12-30 | Univ Kyoto | Pluripotent stem cell for neuronal differentiation induction |
EP2980207B1 (en) | 2013-03-25 | 2018-12-05 | Foundation for Biomedical Research and Innovation at Kobe | Cell sorting method |
CN105358680B (en) | 2013-04-03 | 2019-06-25 | 富士费勒姆细胞动力学有限公司 | Method and composition for the culture entoderm progenitor cells that suspend |
WO2014161075A1 (en) | 2013-04-05 | 2014-10-09 | University Health Network | Methods and compositions for generating chondrocyte lineage cells and/or cartilage like tissue |
WO2014168585A1 (en) | 2013-04-10 | 2014-10-16 | Agency For Science, Technology And Research | Polycaprolactone microcarriers for stem cell culture and fabrication thereof |
EP2985344B1 (en) | 2013-04-12 | 2018-07-18 | Kyoto University | Method for inducing alveolar epithelium progenitor cells |
HUE052516T2 (en) | 2013-04-12 | 2021-05-28 | Houston Methodist Hospital | Improving organs for transplantation |
WO2014174470A1 (en) | 2013-04-23 | 2014-10-30 | Yeda Research And Development Co. Ltd. | Isolated naive pluripotent stem cells and methods of generating same |
ES2753323T3 (en) | 2013-04-30 | 2020-04-08 | Univ Leuven Kath | Cell therapy for myelodysplastic syndromes |
WO2014185358A1 (en) | 2013-05-14 | 2014-11-20 | 国立大学法人京都大学 | Efficient myocardial cell induction method |
US9758763B2 (en) | 2013-05-29 | 2017-09-12 | The Regents Of The University Of California | Methods and compositions for somatic cell proliferation and viability |
CN113648323A (en) | 2013-06-05 | 2021-11-16 | 再生疗法有限公司 | Compositions and methods for induced tissue regeneration in mammalian species |
US10119122B2 (en) | 2013-06-10 | 2018-11-06 | Academisch Ziekenhuis Leiden | Differentiation and expansion of endothelial cells from pluripotent stem cells and the in vitro formation of vasculature like structures |
WO2014200905A2 (en) | 2013-06-10 | 2014-12-18 | President And Fellows Of Harvard College | Early developmental genomic assay for characterizing pluripotent stem cell utility and safety |
DK3008168T3 (en) | 2013-06-11 | 2020-05-04 | Harvard College | SC-CELLS AND COMPOSITIONS AND PROCEDURE FOR CREATING THEREOF |
EP3020803B1 (en) | 2013-06-11 | 2020-03-11 | Kyoto University | Method for producing renal precursor cells |
JP6493881B2 (en) | 2013-06-12 | 2019-04-03 | 国立大学法人京都大学 | Method for selecting induced pluripotent stem cells and method for inducing differentiation into blood cells |
US9624471B2 (en) | 2013-06-12 | 2017-04-18 | University Of Washington Through Its Center For Commercialization | Methods for maturing cardiomyocytes and uses thereof |
CA2913478C (en) | 2013-06-28 | 2021-08-24 | Otsuka Pharmaceutical Factory, Inc. | Trehalose- and dextran-containing solution for transplanting mammalian cells |
EP3031905A4 (en) | 2013-08-07 | 2017-04-26 | Kyoto University | Method for producing pancreatic hormone-producing cell |
KR102473199B1 (en) | 2013-08-16 | 2022-12-01 | 예일 유니버시티 | Epithelial cell differentiation of human mesenchymal stromal cells |
EP3569699A1 (en) | 2013-09-04 | 2019-11-20 | Otsuka Pharmaceutical Factory, Inc. | Method for preparing pluripotent stem cells |
CA2923592A1 (en) | 2013-09-05 | 2015-03-12 | Kyoto University | Method for inducing dopamine-producing neural precursor cells from pluripotent stem cells |
SG11201601922PA (en) | 2013-09-13 | 2016-04-28 | Univ Health Network | Methods and compositions for generating epicardium cells |
CN105960453A (en) | 2013-10-01 | 2016-09-21 | 卡迪马干细胞有限公司 | Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (ALS) |
US10100283B2 (en) | 2013-11-01 | 2018-10-16 | Kyoto University | Efficient chondrocyte induction method |
WO2015069736A1 (en) | 2013-11-08 | 2015-05-14 | The Mclean Hospital Corporation | METHODS FOR EFFICIENT GENERATION OF GABAergic INTERNEURONS FROM PLURIPOTENT STEM CELLS |
US9932607B2 (en) | 2013-11-15 | 2018-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Site-specific integration of transgenes into human cells |
WO2015073918A1 (en) | 2013-11-16 | 2015-05-21 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
WO2015071474A2 (en) | 2013-11-18 | 2015-05-21 | Crispr Therapeutics Ag | Crispr-cas system materials and methods |
WO2015087231A1 (en) | 2013-12-11 | 2015-06-18 | Pfizer Limited | Method for producing retinal pigment epithelial cells |
WO2015089277A1 (en) | 2013-12-12 | 2015-06-18 | The Regents Of The University Of California | Methods and compositions for modifying a single stranded target nucleic acid |
EP2896688A1 (en) | 2014-01-20 | 2015-07-22 | Centre National de la Recherche Scientifique (CNRS) | A method of producing beta pancreatic cells from progenitor cells through the use of hydrogen peroxide |
EP3096713B1 (en) | 2014-01-23 | 2022-09-21 | President and Fellows of Harvard College | Engineered polymeric valves, tubular structures and sheets |
EP3099801B1 (en) | 2014-01-31 | 2020-03-18 | Factor Bioscience Inc. | Synthetic rna for use in the treatment of dystrophic epidermolysis bullosa |
WO2015119642A1 (en) | 2014-02-10 | 2015-08-13 | The Johns Hopkins University | Low oxygen tension enhances endothelial fate of human pluripotent stem cells |
US11078462B2 (en) | 2014-02-18 | 2021-08-03 | ReCyte Therapeutics, Inc. | Perivascular stromal cells from primate pluripotent stem cells |
KR102460549B1 (en) | 2014-03-04 | 2022-10-28 | 페이트 세러퓨틱스, 인코포레이티드 | Improved reprogramming methods and cell culture platforms |
US11066649B2 (en) | 2014-03-19 | 2021-07-20 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method for inducing human cholangiocyte differentiation |
KR102443578B1 (en) | 2014-03-19 | 2022-09-16 | 브이셀 세라퓨틱스 인코포레이티드 | Methods relating to pluripotent cells |
WO2015140005A1 (en) | 2014-03-19 | 2015-09-24 | Ifom Fondazione Istituto Firc Di Oncologia Molecolare | Method of generation of pluripotent cells |
ES2837840T3 (en) | 2014-03-20 | 2021-07-01 | Ares Trading Sa | Quantitative measurement of developmental kinetics of human morula and blastocyst morphology |
WO2015143342A1 (en) | 2014-03-21 | 2015-09-24 | Cellular Dynamics International, Inc. | Production of midbrain dopaminergic neurons and methods for the use thereof |
WO2015164228A1 (en) | 2014-04-21 | 2015-10-29 | Cellular Dynamics International, Inc. | Hepatocyte production via forward programming by combined genetic and chemical engineering |
EP3954759A1 (en) | 2014-05-16 | 2022-02-16 | Janssen Biotech, Inc. | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
WO2015186128A1 (en) | 2014-06-02 | 2015-12-10 | Kadimastem Ltd. | Methods of inducing myelination and maturation of oligodendrocytes |
US10240127B2 (en) | 2014-07-03 | 2019-03-26 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
WO2016010002A1 (en) | 2014-07-14 | 2016-01-21 | 中外製薬株式会社 | Method for identifying epitope of protein |
US11920164B2 (en) | 2014-07-30 | 2024-03-05 | Yeda Research And Development Co. Ltd. | Media for culturing naive human pluripotent stem cells |
US20180363070A9 (en) | 2014-08-12 | 2018-12-20 | Univ Wayne State | Systems and methods to detect stem cell stress and uses thereof |
US10596200B2 (en) | 2014-08-22 | 2020-03-24 | Procella Therapeutics Ab | Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells |
WO2016029122A1 (en) | 2014-08-22 | 2016-02-25 | Chien Kenneth R | Use of jagged 1/frizzled 4 as a cell surface marker for isolating human cardiac ventricular progenitor cells |
EP3188763B1 (en) | 2014-09-02 | 2020-05-13 | The Regents of The University of California | Methods and compositions for rna-directed target dna modification |
EP3842514A1 (en) | 2014-09-12 | 2021-06-30 | Whitehead Institute for Biomedical Research | Cells expressing apolipoprotein e and uses thereof |
JP6841753B2 (en) | 2014-09-15 | 2021-03-10 | ザ チルドレンズ メディカル センター コーポレーション | Methods and compositions for increasing somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation |
US9371516B2 (en) | 2014-09-19 | 2016-06-21 | Regenerative Medical Solutions, Inc. | Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells |
JP6581655B2 (en) | 2014-10-14 | 2019-09-25 | フジフィルム セルラー ダイナミクス,インコーポレイテッド | Generation of pluripotent stem cell-derived keratinocytes and maintenance of keratinocyte culture |
CN107148275A (en) | 2014-10-20 | 2017-09-08 | 神经干细胞公司 | The NSC of the stabilization of exogenous polynucleotide comprising encoding growth hormone and its application method |
DK3211071T3 (en) | 2014-10-24 | 2021-07-26 | Sumitomo Dainippon Pharma Co Ltd | MANUFACTURING PROCEDURE FOR RETINAL TISSUE |
EP3220945A2 (en) | 2014-11-17 | 2017-09-27 | Yeda Research and Development Co., Ltd. | Methods of treating diseases related to mitochondrial function |
AU2015353853B2 (en) | 2014-11-25 | 2020-10-15 | President And Fellows Of Harvard College | Methods for generation of podocytes from pluripotent stem cells and cells produced by the same |
US20160215268A1 (en) | 2014-12-19 | 2016-07-28 | Janssen Biotech, Inc. | Suspension Culturing of Pluripotent Stem Cells |
WO2016103269A1 (en) | 2014-12-23 | 2016-06-30 | Ramot At Tel-Aviv University Ltd. | Populations of neural progenitor cells and methods of producing and using same |
IL305070A (en) | 2014-12-30 | 2023-10-01 | Cell Cure Neurosciences Ltd | Rpe cell populations and methods of generating same |
CA2972580A1 (en) | 2014-12-30 | 2016-07-07 | Cell Cure Neurosciences Ltd. | Assessing retinal pigment epithelial cell populations |
WO2016118824A1 (en) | 2015-01-22 | 2016-07-28 | Regenerative Medical Solutions, Inc. | Markers for differentiation of stem cells into differentiated cell populations |
CA2976376A1 (en) | 2015-02-13 | 2016-08-18 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
WO2016131137A1 (en) | 2015-02-17 | 2016-08-25 | University Health Network | Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes |
EP3059307B2 (en) | 2015-02-20 | 2022-05-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of a laminin for differentiating pluripotent cells into hepatocyte lineage cells |
EP3266864A4 (en) | 2015-03-06 | 2018-08-29 | Kyoto University | Method for inducing differentiation of alveolar epithelial cells |
US10772917B2 (en) | 2015-03-11 | 2020-09-15 | Ccs Ventures Limited | Pancreatic endocrine progenitor cell therapies for the treatment of obesity and type 2 diabetes (T2D) |
WO2016185457A1 (en) | 2015-05-19 | 2016-11-24 | Yeda Research And Development Co. Ltd. | Methods of promoting lymphangiogenesis |
WO2017014165A1 (en) | 2015-07-17 | 2017-01-26 | 国立大学法人京都大学 | Method for inducing vascular endothelial cells |
ES2865024T3 (en) | 2015-07-29 | 2021-10-14 | Hadasit Med Res Service | Large-scale production of retinal pigment epithelium cells |
ES2932823T3 (en) | 2015-08-05 | 2023-01-26 | Cell Cure Neurosciences Ltd | Preparation of retinal pigment epithelium cells |
CN108138145A (en) | 2015-08-05 | 2018-06-08 | 细胞治疗神经科学有限公司 | For treating the preparation of the photoreceptor of retinal disease |
US11312940B2 (en) | 2015-08-31 | 2022-04-26 | University Of Louisville Research Foundation, Inc. | Progenitor cells and methods for preparing and using the same |
WO2017043605A1 (en) | 2015-09-08 | 2017-03-16 | 大日本住友製薬株式会社 | Method for producing retinal pigment epithelial cells |
DK3347456T3 (en) | 2015-09-08 | 2024-02-19 | Us Health | PROCEDURE FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIAL CELLS |
DK3347457T3 (en) | 2015-09-08 | 2022-01-17 | Fujifilm Cellular Dynamics Inc | MACS-based purification of stem cell-derived retinal pigment epithelium |
CA2998096C (en) | 2015-09-11 | 2024-01-30 | Astellas Pharma Inc. | Method for producing renal progenitor cells |
WO2017064546A1 (en) | 2015-09-24 | 2017-04-20 | Crispr Therapeutics Ag | Novel family of rna-programmable endonucleases and their uses in genome editing and other applications |
KR20180055918A (en) | 2015-10-16 | 2018-05-25 | 페이트 세러퓨틱스, 인코포레이티드 | Platform for the induction and maintenance of ground-state versatility |
WO2017070145A1 (en) | 2015-10-19 | 2017-04-27 | Cellular Dynamics International, Inc. | Production of virus-receptive pluripotent stem cell (psc)-derived hepatocytes |
JP6976939B2 (en) | 2015-10-20 | 2021-12-08 | フジフィルム セルラー ダイナミクス,インコーポレイテッド | Creation of multilineage hematopoietic progenitor cells by genetic programming |
WO2017072763A1 (en) | 2015-10-26 | 2017-05-04 | Cell Cure Neurosciences Ltd. | Preparation of retinal pigment epithelium cells |
WO2017075389A1 (en) | 2015-10-30 | 2017-05-04 | The Regents Of The Universtiy Of California | Methods of generating t-cells from stem cells and immunotherapeutic methods using the t-cells |
IL259470B (en) | 2015-11-18 | 2022-08-01 | Univ Georgia | Neural cell extracellular vessicles |
EP3387112A4 (en) | 2015-12-07 | 2019-08-21 | BioTime, Inc. | Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells |
EP3397753B1 (en) | 2015-12-30 | 2021-10-27 | FUJIFILM Cellular Dynamics, Inc. | Microtissue formation using stem cell-derived human hepatocytes |
WO2017172086A1 (en) | 2016-02-19 | 2017-10-05 | Leung Chuen Yan | Genetic markers for engraftment of human cardiac ventricular progenitor cells |
US11674952B2 (en) | 2016-02-24 | 2023-06-13 | The Rockefeller University | Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof |
EP3423568A4 (en) | 2016-03-04 | 2019-11-13 | University Of Louisville Research Foundation, Inc. | Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (vsels) |
WO2017153982A1 (en) | 2016-03-06 | 2017-09-14 | Yeda Research And Development Co. Ltd. | Method for modulating myelination |
US11534466B2 (en) | 2016-03-09 | 2022-12-27 | Aal Scientifics, Inc. | Pancreatic stem cells and uses thereof |
CA3019357A1 (en) | 2016-04-04 | 2017-10-12 | Biotime, Inc. | Pluripotent stem cell-derived 3d retinal tissue and uses thereof |
MA45479A (en) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN ENDODERMAL CELLS OF MIDDLE INTESTINE |
CN109072198B (en) | 2016-04-22 | 2022-08-26 | 国立大学法人京都大学 | Preparation method of dopamine-producing neural progenitor cells |
WO2017202814A1 (en) | 2016-05-24 | 2017-11-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of neuropathological disorders characterized by a loss of cortical neurons |
AU2017270234B2 (en) | 2016-05-25 | 2023-11-23 | Assistance Publique-Hôpitaux De Paris (Aphp) | Methods and compositions for treating cancers |
US20200325449A1 (en) | 2016-06-02 | 2020-10-15 | The Cleveland Clinic Foundation | Complement inhibition for improving cell viability |
WO2017216771A2 (en) | 2016-06-17 | 2017-12-21 | Genesis Technologies Limited | Crispr-cas system, materials and methods |
MA45502A (en) | 2016-06-21 | 2019-04-24 | Janssen Biotech Inc | GENERATION OF FUNCTIONAL BETA CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS WITH GLUCOSE-DEPENDENT MITOCHONDRIAL RESPIRATION AND TWO-PHASE INSULIN SECRETION RESPONSE |
AU2017290805B2 (en) | 2016-07-01 | 2023-11-16 | Research Development Foundation | Elimination of proliferating cells from stem cell-derived grafts |
EP3478824A1 (en) | 2016-07-01 | 2019-05-08 | Centre National de la Recherche Scientifique - CNRS | Amplifying beta cell differentiation with small molecules bet (bromodomain and extraterminal family of bromodomain-containing proteins) inhibitors |
EP3500664B1 (en) | 2016-08-16 | 2021-09-22 | FUJIFILM Cellular Dynamics, Inc. | Methods for differentiating pluripotent cells |
CA3033788A1 (en) | 2016-08-17 | 2018-02-22 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
AU2017340634B2 (en) | 2016-10-05 | 2022-06-02 | FUJIFILM Cellular Dynamics, Inc. | Generating mature lineages from induced pluripotent stem cells with MECP2 disruption |
CN110167349A (en) | 2016-11-02 | 2019-08-23 | Aal科学有限公司 | Non- mesenchyma people Lung stem cells and the method that they are used to treat respiratory disorder |
WO2018084228A1 (en) | 2016-11-04 | 2018-05-11 | 国立大学法人東京大学 | Solution for cryopreservation of animal cells or animal tissues, cryopreserved product, and cryopreservation method |
WO2018089011A1 (en) | 2016-11-10 | 2018-05-17 | Viacyte, Inc | Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof |
CA3044509A1 (en) | 2016-11-25 | 2018-05-31 | Riken | Cell population for transplantation and method for producing same |
US10508263B2 (en) | 2016-11-29 | 2019-12-17 | Procella Therapeutics Ab | Methods for isolating human cardiac ventricular progenitor cells |
CN110072992A (en) | 2016-12-14 | 2019-07-30 | 株式会社大塚制药工场 | Mammalian cell freezen protective liquid |
US10828330B2 (en) | 2017-02-22 | 2020-11-10 | IO Bioscience, Inc. | Nucleic acid constructs comprising gene editing multi-sites and uses thereof |
JP7007686B2 (en) | 2017-03-08 | 2022-01-25 | 大日本住友製薬株式会社 | Manufacturing method of retinal pigment epithelial cells |
CN110913874A (en) | 2017-03-16 | 2020-03-24 | 谱系细胞疗法公司 | Method for measuring the efficacy of a retinal disease therapy |
US20200131473A1 (en) | 2017-03-20 | 2020-04-30 | Ifom Fondazione Istituto Firc Di Oncologia Molecolare | Method of generating 2 cell-like stem cells |
EP4083063A3 (en) | 2017-04-18 | 2023-01-04 | FUJIFILM Cellular Dynamics, Inc. | Antigen-specific immune effector cells |
US20210130849A1 (en) | 2017-04-20 | 2021-05-06 | Oregon Health & Science University | Human gene correction |
KR102422175B1 (en) | 2017-06-19 | 2022-07-18 | 고에키 자이단 호징 고베 이료 산교 도시 스이신 기코 | Method for predicting differentiation capacity of pluripotent stem cells and reagents therefor |
KR20200029479A (en) | 2017-07-20 | 2020-03-18 | 고쿠리쓰 겐큐 가이하쓰 호징 리가가쿠 겐큐소 | Methods of preservation of nerve tissue |
EP3656852A4 (en) | 2017-07-20 | 2021-04-21 | Riken | Method for maturation of retinal tissue containing continuous epithelium |
JP2020530839A (en) | 2017-07-31 | 2020-10-29 | バイオタイム インコーポレイテッド | Compositions and Methods for Recovering or Preventing Visual Loss Caused by Disease or Traumatic Injury |
DK3487988T3 (en) | 2017-08-23 | 2020-02-03 | Procella Therapeutics Ab | USE OF NEUROPILIN-1 (NRP1) AS A CELL SURFACE COLLECTOR FOR INSULATING HUMAN HEART VENTRICULAR STEM CELLS |
CA3074426A1 (en) | 2017-09-08 | 2019-03-14 | Sumitomo Dainippon Pharma Co., Ltd. | Cell aggregate including retinal tissue and production method therefor |
JP7360583B2 (en) | 2017-09-14 | 2023-10-13 | 国立研究開発法人理化学研究所 | Method for manufacturing retinal tissue |
CA3075883A1 (en) | 2017-09-14 | 2019-03-21 | Riken | Method for amplifying cone photoreceptors or rod photoreceptors using dorsalization signal transmitter or ventralization signal transmitter |
MA50578A (en) | 2017-11-09 | 2021-09-15 | Vertex Pharma | CRISPR / CAS SYSTEMS FOR THE TREATMENT OF DMD |
JP7271539B2 (en) | 2017-11-14 | 2023-05-11 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Regulatory T cells genetically modified for the lymphotoxin alpha gene and uses thereof |
WO2019103125A1 (en) | 2017-11-24 | 2019-05-31 | 住友化学株式会社 | Production method for cell mass including neural cells/tissue and non-neural epithelial tissue, and cell mass from same |
CN111670043A (en) | 2017-11-24 | 2020-09-15 | 国家医疗保健研究所 | Methods and compositions for treating cancer |
CN111386336A (en) | 2017-11-24 | 2020-07-07 | 住友化学株式会社 | Method for producing cell mass containing pituitary tissue and cell mass |
CA3084825A1 (en) | 2017-12-14 | 2019-06-20 | Crispr Therapeutics Ag | Novel rna-programmable endonuclease systems and their use in genome editing and other applications |
EP4000568A1 (en) | 2017-12-29 | 2022-05-25 | Cell Cure Neurosciences Ltd. | Retinal pigment epithelium cell compositions |
JP7414530B2 (en) | 2018-02-19 | 2024-01-16 | 住友ファーマ株式会社 | Cell aggregates, mixtures of cell aggregates, and methods for producing them |
EP3768834A1 (en) | 2018-03-19 | 2021-01-27 | CRISPR Therapeutics AG | Novel rna-programmable endonuclease systems and uses thereof |
US11401264B2 (en) | 2018-03-30 | 2022-08-02 | Orizuru Therapeutics, Inc. | Heterocyclic compound |
WO2019189554A1 (en) | 2018-03-30 | 2019-10-03 | 国立大学法人京都大学 | Cardiomyocyte maturation promoter |
CA3097428A1 (en) | 2018-04-20 | 2019-10-24 | FUJIFILM Cellular Dynamics, Inc. | Method for differentiation of ocular cells and use thereof |
EP3788138A1 (en) | 2018-05-02 | 2021-03-10 | Novartis AG | Regulators of human pluripotent stem cells and uses thereof |
EP3572512A1 (en) | 2018-05-24 | 2019-11-27 | B.R.A.I.N. Ag | A method for engineering a protein |
EP3813861A4 (en) | 2018-06-27 | 2022-08-10 | Juvena Therapeutics, Inc. | Heparin-associated polypeptides and uses thereof |
JP7285015B2 (en) | 2018-07-19 | 2023-06-01 | 国立大学法人京都大学 | Lamellar cartilage derived from pluripotent stem cells and method for producing the same |
EP3828262A4 (en) | 2018-07-23 | 2022-03-30 | Kyoto University | Novel renal progenitor cell marker and method for concentrating renal progenitor cells using same |
CN112703011A (en) | 2018-08-06 | 2021-04-23 | 国家医疗保健研究所 | Methods and compositions for treating cancer |
CA3108275A1 (en) | 2018-08-10 | 2020-02-13 | Vertex Pharmaceuticals Incorporated | Stem cell derived islet differentiation |
EP3842527A4 (en) | 2018-08-24 | 2022-05-18 | Sumitomo Chemical Company Limited | Cell aggregation including olfactory neuron or precursor cell thereof, and method for producing same |
CA3112902A1 (en) | 2018-09-28 | 2020-04-02 | Otsuka Pharmaceutical Factory, Inc. | Mammal cell preserving solution containing acarbose or stachyose |
WO2020090903A1 (en) | 2018-10-31 | 2020-05-07 | 国立大学法人京都大学 | Method for producing pluripotent stem cell having released differentiation resistance to mesendoderm |
WO2020100481A1 (en) | 2018-11-15 | 2020-05-22 | Jsr株式会社 | Method for producing brain organoids |
SG11202104401RA (en) | 2018-11-19 | 2021-05-28 | The United States Of America As Represented By The Secretary | Biodegradable tissue replacement implant and its use |
US20210380950A1 (en) | 2018-11-28 | 2021-12-09 | Milica Radisic | Methods for tissue generation |
CN113207297A (en) | 2018-12-20 | 2021-08-03 | 住友化学株式会社 | Cell population comprising embryo-type erythroblasts, method for producing same, cell culture composition, and method for testing compound |
EP3900787A4 (en) | 2018-12-21 | 2022-02-23 | Kyoto University | Lubricin-localized cartilage-like tissue, method for producing same and composition comprising same for treating articular cartilage damage |
EP3903789A4 (en) | 2018-12-28 | 2022-10-05 | Riken | Therapeutic drug for disease accompanied by disorders in retinal system cells or retinal tissue |
EP3914698A1 (en) | 2019-01-23 | 2021-12-01 | Yeda Research and Development Co. Ltd | Culture media for pluripotent stem cells |
EP3923718A1 (en) | 2019-02-13 | 2021-12-22 | TiGenix, S.A.U. | Cryopreservation of stem cells |
SG11202108114YA (en) | 2019-02-27 | 2021-08-30 | Tigenix S A U | Improved stem cell populations for allogeneic therapy |
GB2595606B (en) | 2019-03-07 | 2022-09-21 | Univ California | CRISPR-Cas effector polypeptides and methods of use thereof |
WO2020209959A1 (en) | 2019-03-08 | 2020-10-15 | Crispr Therapeutics Ag | Nucleobase-editing fusion protein systems, compositions, and uses thereof |
AU2020239225A1 (en) | 2019-03-12 | 2021-09-30 | Bayer Healthcare Llc | Novel high fidelity RNA-programmable endonuclease systems and uses thereof |
CA3132804A1 (en) | 2019-03-13 | 2020-09-17 | Sumitomo Dainippon Pharma Co., Ltd. | Method for evaluating quality of transplant neural retina, and transplant neural retina sheet |
EP3950953A4 (en) | 2019-03-29 | 2023-04-19 | Public University Corporation Yokohama City University | Screening method and toxicity evaluation method |
EP3957366A4 (en) | 2019-04-26 | 2023-01-04 | Riken | Composite including neural retina, retinal pigment epithelial cells, and hydrogel, and method for producing same |
TW202106870A (en) | 2019-04-26 | 2021-02-16 | 日商大塚製藥工場股份有限公司 | Trehalose-containing liquid for mammalian cell preservation |
US20210047649A1 (en) | 2019-05-08 | 2021-02-18 | Vertex Pharmaceuticals Incorporated | Crispr/cas all-in-two vector systems for treatment of dmd |
KR20220007879A (en) | 2019-05-09 | 2022-01-19 | 후지필름 셀룰러 다이내믹스, 인코포레이티드 | How to generate hepatocytes |
JP2022533591A (en) | 2019-05-14 | 2022-07-25 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | Regulatory T cells targeted by lymphotoxin alpha blockers and their uses |
EP3973049A1 (en) | 2019-05-22 | 2022-03-30 | Hadasit Medical Research Services and Development Ltd. | Methods of culturing human pluripotent cells |
EP3754014A1 (en) | 2019-06-21 | 2020-12-23 | Centre d'Etude des Cellules Souches (CECS) | Automated method for preparing retinal pigment epithelium cells |
EP3990624A1 (en) | 2019-06-25 | 2022-05-04 | Vertex Pharmaceuticals Incorporated | Enhanced differentiation of beta cells |
JP7385244B2 (en) | 2019-06-27 | 2023-11-22 | 国立大学法人 東京大学 | Method for isolating pancreatic progenitor cells |
US10501404B1 (en) | 2019-07-30 | 2019-12-10 | Factor Bioscience Inc. | Cationic lipids and transfection methods |
WO2021030424A1 (en) | 2019-08-13 | 2021-02-18 | Semma Therapeutics, Inc. | Pancreatic differentiation |
WO2021045217A1 (en) | 2019-09-06 | 2021-03-11 | 学校法人慶應義塾 | Method for producing cell aggregate including glial progenitor cells |
US20240083973A1 (en) | 2019-10-09 | 2024-03-14 | Ecole Normale Supérieure de Lyon | T cells modified to express mutated cxcr4 or partially deleted and uses thereof |
CN115003156A (en) | 2019-11-20 | 2022-09-02 | 住友制药株式会社 | Method for freezing cell aggregates |
WO2021100829A1 (en) | 2019-11-20 | 2021-05-27 | 大日本住友製薬株式会社 | Method for freezing neural cells |
WO2021106832A1 (en) | 2019-11-25 | 2021-06-03 | 国立大学法人京都大学 | T-cell master cell bank |
JP2023504013A (en) | 2019-11-29 | 2023-02-01 | ノヴァディップ バイオサイエンシズ | Biomaterials for prevention and treatment of tissue damage |
CN114929243A (en) | 2019-11-29 | 2022-08-19 | 诺瓦迪普生物科学股份公司 | Pharmaceutical composition based on miRNA and use thereof for preventing and treating tissue pathologies |
US20230030814A1 (en) | 2019-12-12 | 2023-02-02 | National University Corporation Chiba University | Freeze-Dried Preparations Comprising Megakaryocytes and Platelets |
EP3875581A1 (en) | 2020-03-02 | 2021-09-08 | Centre d'Etude des Cellules Souches (CECS) | Automated method for preparing keratinocytes |
EP3875580A1 (en) | 2020-03-02 | 2021-09-08 | Centre d'Etude des Cellules Souches (CECS) | Methods for preparing keratinocytes |
BR112022018101A2 (en) | 2020-03-13 | 2022-11-22 | Goliver Therapeutics | LIVER STEM-TYPE CELLS FOR TREATMENT AND/OR PREVENTION OF FULLMINANT LIVER DISORDERS |
US20230136878A1 (en) | 2020-03-19 | 2023-05-04 | Orizuru Therapeutics, Inc. | Cardiomyocyte purification method |
EP4123016A1 (en) | 2020-03-19 | 2023-01-25 | Orizuru Therapeutics, Inc. | Method for purifying cardiomyocytes |
EP4132479A1 (en) | 2020-04-07 | 2023-02-15 | Ramot at Tel-Aviv University Ltd. | Cannabidiol-containing compositions and uses thereof |
EP4157865A1 (en) | 2020-05-29 | 2023-04-05 | FUJIFILM Cellular Dynamics, Inc. | Bilayer of retinal pigmented epithelium and photoreceptors and use thereof |
JP2023528377A (en) | 2020-05-29 | 2023-07-04 | フジフィルム セルラー ダイナミクス,インコーポレイテッド | Double cell aggregates of retinal pigment epithelium and photoreceptors and methods of use thereof |
WO2021250058A2 (en) | 2020-06-12 | 2021-12-16 | Bayer Aktiengesellschaft | CRISPR-Cas12a DIRECTED RANDOM MUTAGENESIS AGENTS AND METHODS |
EP4180516A4 (en) | 2020-07-13 | 2024-01-17 | Univ Kyoto | Skeletal muscle precursor cells and method for purifying same, composition for treating myogenic diseases, and method for producing cell group containing skeletal muscle precursor cells |
US20230310614A1 (en) | 2020-09-11 | 2023-10-05 | Sumitomo Pharma Co., Ltd. | Medium for Tissue for Transplantation |
WO2022054925A1 (en) | 2020-09-11 | 2022-03-17 | 国立研究開発法人理化学研究所 | Complex containing neural retina-containing cell aggregates and matrix, and method for manufacturing same |
US20230332109A1 (en) | 2020-09-24 | 2023-10-19 | Institute Of Zoology, Chinese Academy Of Sciences | Activated pluripotent stem cell, and preparation method therefor and use thereof |
WO2022079322A1 (en) | 2020-10-16 | 2022-04-21 | Fundació Centre De Regulació Genòmica | Therapy for degenerative disease and tissue damage |
EP4005577A1 (en) | 2020-11-26 | 2022-06-01 | Novadip Biosciences | Cellular and/or extracellular extracts for preventing and/or treating cancer and/or inflammation |
CN112538458A (en) | 2020-11-26 | 2021-03-23 | 北京赛尔湃腾科技咨询合伙企业(有限合伙) | Method for reprogramming cells |
WO2022138101A1 (en) | 2020-12-23 | 2022-06-30 | 三井化学株式会社 | Culture member and use thereof |
EP4306634A1 (en) | 2021-03-09 | 2024-01-17 | Riken | Method for producing hypoimmunogenic retinal pigment epithelial cells |
WO2022207889A1 (en) | 2021-04-01 | 2022-10-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Liver organoid manufacturing methods, liver organoids obtained with the same, and uses thereof |
CA3213988A1 (en) | 2021-04-07 | 2022-10-13 | Christopher MCMAHON | Dopaminergic precursor cells and methods of use |
CA3216537A1 (en) | 2021-04-11 | 2022-10-20 | President And Fellows Of Harvard College | Cardiomyocytes and compositions and methods for producing the same |
CN117242173A (en) | 2021-05-03 | 2023-12-15 | 安斯泰来再生医药协会 | Method for producing mature corneal endothelial cells |
CA3217861A1 (en) | 2021-05-07 | 2022-11-10 | Astellas Institute For Regenerative Medicine | Methods of generating mature hepatocytes |
WO2022251477A1 (en) | 2021-05-28 | 2022-12-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Biodegradable tissue scaffold with secondary matrix to host weakly adherent cells |
WO2022251499A1 (en) | 2021-05-28 | 2022-12-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods to generate macular, central and peripheral retinal pigment epithelial cells |
WO2022258511A1 (en) | 2021-06-07 | 2022-12-15 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for generating highly functional hepatocytes by differentiating hepatoblasts |
TW202303145A (en) | 2021-06-09 | 2023-01-16 | 美商譜系細胞治療公司 | Methods and compositions for treating retinal diseases and conditions |
EP4101928A1 (en) | 2021-06-11 | 2022-12-14 | Bayer AG | Type v rna programmable endonuclease systems |
CA3222950A1 (en) | 2021-06-11 | 2022-12-15 | Bayer Aktiengesellschaft | Type v rna programmable endonuclease systems |
JPWO2022265086A1 (en) | 2021-06-17 | 2022-12-22 | ||
IL310156A (en) | 2021-07-28 | 2024-03-01 | Lineage Cell Therapeutics Inc | Expansion of retinal pigment epithelium cells |
EP4144841A1 (en) | 2021-09-07 | 2023-03-08 | Bayer AG | Novel small rna programmable endonuclease systems with impoved pam specificity and uses thereof |
US20230078230A1 (en) | 2021-09-13 | 2023-03-16 | FUJIFILM Cellular Dynamics, Inc. | Methods for the production of committed cardiac progenitor cells |
WO2023049826A1 (en) | 2021-09-23 | 2023-03-30 | President And Fellows Of Harvard College | Genetically encoded voltage indicators and uses thereof |
US20230226116A1 (en) | 2021-10-20 | 2023-07-20 | University Of Rochester | Method for rejuvenating glial progenitor cells and rejuvenated glial progenitor cells per se |
WO2023069987A1 (en) | 2021-10-20 | 2023-04-27 | University Of Rochester | Rejuvenation treatment of age-related white matter loss cross reference to related application |
WO2023070019A1 (en) | 2021-10-21 | 2023-04-27 | Vertex Pharmaceuticals Incorporated | Hypoimmune cells |
WO2023077140A2 (en) | 2021-11-01 | 2023-05-04 | Vertex Pharmaceuticals Incorporated | Stem cell derived pancreatic islet differentiation |
WO2023095149A1 (en) | 2021-11-29 | 2023-06-01 | Ramot At Tel-Aviv University Ltd. | Methods and compositions for treating spinal cord injury |
WO2023118068A1 (en) | 2021-12-23 | 2023-06-29 | Bayer Aktiengesellschaft | Novel small type v rna programmable endonuclease systems |
WO2023167986A1 (en) | 2022-03-02 | 2023-09-07 | Lineage Cell Therapeutics, Inc. | Methods and compositions for treating hearing loss |
WO2023178239A1 (en) | 2022-03-16 | 2023-09-21 | The Children's Medical Center Corporation | Hpsc-derived articular chondrocyte compositions, systems and methods of use thereof |
US20230330264A1 (en) | 2022-04-15 | 2023-10-19 | Smartcella Solutions Ab | COMPOSITIONS AND METHODS FOR EXOSOME-MEDIATED DELIVERY OF mRNA AGENTS |
WO2023211857A1 (en) | 2022-04-25 | 2023-11-02 | Lineage Cell Therapeutics, Inc. | Methods and compositions for treating vision loss |
WO2023215455A1 (en) | 2022-05-05 | 2023-11-09 | University Of Rochester | Dual macroglial-microglial approach towards therapeutic cell replacement in neurodegenerative and neuropsychiatric disease |
WO2023230391A1 (en) | 2022-05-26 | 2023-11-30 | Tender Food, Inc. | Plant-based shredded meat products, and methods of producing the same |
WO2023237587A1 (en) | 2022-06-10 | 2023-12-14 | Bayer Aktiengesellschaft | Novel small type v rna programmable endonuclease systems |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3060078A (en) * | 1960-12-02 | 1962-10-23 | Burlington Industries Inc | Bonding of polyethylene terephthalate fibers to certain rubbers |
BE637575A (en) * | 1962-09-21 | 1900-01-01 | ||
WO1990001541A1 (en) | 1988-08-04 | 1990-02-22 | Amrad Corporation Limited | In vitro propagation of embryonic stem cells |
US20030032178A1 (en) * | 1988-08-04 | 2003-02-13 | Williams Robert Lindsay | In vitro propagation of embryonic stem cells |
JP2750464B2 (en) * | 1990-01-30 | 1998-05-13 | 日本ゼオン株式会社 | Method for producing fiber-rubber composite |
US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5340740A (en) | 1992-05-15 | 1994-08-23 | North Carolina State University | Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process |
US5589376A (en) | 1992-07-27 | 1996-12-31 | California Institute Of Technology | Mammalian neural crest stem cells |
WO1994003585A1 (en) * | 1992-08-04 | 1994-02-17 | Commonwealth Scientific And Industrial Research Organisation | A method for maintaining embryonic stem cells and avian factor useful for same |
US5453357A (en) * | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US5690926A (en) * | 1992-10-08 | 1997-11-25 | Vanderbilt University | Pluripotential embryonic cells and methods of making same |
US5523226A (en) * | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US5449620A (en) * | 1994-01-25 | 1995-09-12 | Thomas Jefferson University | Apparatus and method for culturing embryonic stem cells |
US5541081A (en) * | 1994-03-22 | 1996-07-30 | President And Fellows Of Harvard College | Process for assessing oocyte and embryo quality |
JP3496292B2 (en) * | 1994-09-30 | 2004-02-09 | 日本ゼオン株式会社 | Composites of nitrile group-containing highly saturated copolymer rubber and fiber |
US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5654099A (en) * | 1996-02-21 | 1997-08-05 | Dayco Products, Inc. | Method of improving adhesion between alkylated chlorosulfonated polyethylene (ACSM) or chlorosulfonated polyethylene (CSM), and resorcinol formaldehyde latex (RFL) treated polyester cord |
CA2417356A1 (en) * | 2000-08-01 | 2002-02-07 | Yissum Research Development Company | Directed differentiation of embryonic cells |
US20070077654A1 (en) * | 2004-11-01 | 2007-04-05 | Thomson James A | Platelets from stem cells |
-
1996
- 1996-01-18 US US08/591,246 patent/US5843780A/en not_active Expired - Lifetime
- 1996-01-19 EP EP05024871A patent/EP1640448A3/en not_active Withdrawn
- 1996-01-19 CA CA2190528A patent/CA2190528C/en not_active Expired - Lifetime
- 1996-01-19 WO PCT/US1996/000596 patent/WO1996022362A1/en active Application Filing
- 1996-01-19 EP EP96903521A patent/EP0770125A4/en not_active Withdrawn
- 1996-01-19 AU AU47584/96A patent/AU4758496A/en not_active Abandoned
-
1998
- 1998-06-26 US US09/106,390 patent/US6200806B1/en not_active Expired - Lifetime
-
2001
- 2001-01-16 US US09/761,289 patent/US20010024825A1/en not_active Abandoned
- 2001-10-18 US US09/982,637 patent/US7029913B2/en not_active Expired - Fee Related
-
2003
- 2003-05-06 US US10/430,496 patent/US20060040383A1/en not_active Abandoned
-
2005
- 2005-01-11 US US11/033,335 patent/US20050158854A1/en not_active Abandoned
- 2005-01-14 US US11/036,245 patent/US7582479B2/en not_active Expired - Fee Related
-
2008
- 2008-03-12 US US12/047,135 patent/US7781216B2/en not_active Expired - Fee Related
-
2010
- 2010-06-23 US US12/822,004 patent/US8273569B2/en not_active Expired - Fee Related
-
2012
- 2012-08-27 US US13/595,587 patent/US20120328582A1/en not_active Abandoned
-
2014
- 2014-05-19 US US14/281,341 patent/US20150056698A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7413902B2 (en) | 1997-10-23 | 2008-08-19 | Geron Corporation | Feeder-free culture method for embryonic stem cells or primate primordial stem cells |
US8637311B2 (en) | 1998-10-23 | 2014-01-28 | Asterias Biotherapeutics, Inc. | Human embryonic stem cells genetically modified to contain a nucleic acid and cultured with fibroblast growth factor |
US10059939B2 (en) | 1998-10-23 | 2018-08-28 | Asterias Biotherapeutics, Inc. | Screening methods for human embryonic stem cells |
Also Published As
Publication number | Publication date |
---|---|
EP0770125A4 (en) | 1998-01-14 |
US20150056698A1 (en) | 2015-02-26 |
US5843780A (en) | 1998-12-01 |
EP1640448A3 (en) | 2006-04-26 |
US20090011503A1 (en) | 2009-01-08 |
EP1640448A2 (en) | 2006-03-29 |
WO1996022362A1 (en) | 1996-07-25 |
US20030008392A1 (en) | 2003-01-09 |
US7029913B2 (en) | 2006-04-18 |
US20050164381A1 (en) | 2005-07-28 |
US20060040383A1 (en) | 2006-02-23 |
EP0770125A1 (en) | 1997-05-02 |
US8273569B2 (en) | 2012-09-25 |
US20110256623A1 (en) | 2011-10-20 |
AU4758496A (en) | 1996-08-07 |
US7582479B2 (en) | 2009-09-01 |
US7781216B2 (en) | 2010-08-24 |
CA2190528C (en) | 2010-04-27 |
US20120328582A1 (en) | 2012-12-27 |
US20010024825A1 (en) | 2001-09-27 |
US20050158854A1 (en) | 2005-07-21 |
US6200806B1 (en) | 2001-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2190528A1 (en) | Primate embryonic stem cells | |
Suemori et al. | Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage | |
Reubinoff et al. | Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro | |
Suemori et al. | Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI | |
US6875607B1 (en) | Embryonic stem cells | |
Baharvand et al. | Neural differentiation from human embryonic stem cells in a defined adherent culture condition | |
Strelchenko et al. | Morula-derived human embryonic stem cells | |
RU2007146777A (en) | OBTAINING A LINE OF HUMAN EMBRYONIC STEM CELLS USING MAMMAL CELLS | |
RU2012144428A (en) | PARTENOGENETIC ACTIVATION OF HUMAN OOCYTES TO OBTAIN HUMAN EMBRYONAL STEM CELLS | |
EP0363125A3 (en) | Proliferated pancreatic endocrine cell product and process | |
Suemori et al. | Establishment of the Embryo‐derived Stem (ES) Cell Lines from Mouse Blastocysts: Effects of the Feeder Cell Layer. | |
Pera | Human pluripotent stem cells: a progress report | |
US5532156A (en) | Hepatocyte cell line derived from the epiblast of pig blastocysts | |
Draper et al. | Embryonic stem cells: advances toward potential therapeutic use | |
González et al. | Establishment of mouse embryonic stem cells from isolated blastomeres and whole embryos using three derivation methods | |
WO2006036164A1 (en) | Morula derived embryonic stem cells | |
Tian et al. | Factors derived from mouse embryonic stem cells promote self-renewal of goat embryonic stem-like cells | |
Oshima et al. | Murine embryonal carcinoma hybrids: decreased ability to spontaneously differentiate as a dominant trait | |
JP4317337B2 (en) | Cell line passage enzyme solution and method for culturing and proliferating primate embryonic stem cells using the same | |
AU2003264611B2 (en) | Embryonic stem cells | |
Tan et al. | Derivation of embryonic stem cell line from frozen human embryos and neural differentiation | |
Amit et al. | Human embryonic stem cells | |
Zhou et al. | Establishment and maintenance of three Chinese human embryonic stem cell lines | |
Seshagiri et al. | Reproductive Immunology SK Gupta (Ed) Copyright© 1999 Narosa Publishing House, New Delhi, India |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20160119 |